


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:52:36Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12404983" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12404983</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Lab Anim (NY)</journal-id><journal-id journal-id-type="iso-abbrev">Lab Anim (NY)</journal-id><journal-id journal-id-type="pmc-domain-id">981</journal-id><journal-id journal-id-type="pmc-domain">npgopen</journal-id><journal-title-group><journal-title>Lab Animal</journal-title></journal-title-group><issn pub-type="ppub">0093-7355</issn><issn pub-type="epub">1548-4475</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Nature Portfolio</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12404983</article-id><article-id pub-id-type="pmcid-ver">PMC12404983.1</article-id><article-id pub-id-type="pmcaid">12404983</article-id><article-id pub-id-type="pmcaiid">12404983</article-id><article-id pub-id-type="pmid">40770069</article-id><article-id pub-id-type="doi">10.1038/s41684-025-01588-3</article-id><article-id pub-id-type="publisher-id">1588</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Meta-inflammation and endotoxemia in a highly translational porcine model of diet-induced obesity</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Starb&#230;k</surname><given-names initials="SMR">Sofie M. R.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0006-6838-9798</contrib-id><name name-style="western"><surname>Henriksen</surname><given-names initials="BL">Betina L.</given-names></name><address><email>blyhen@dtu.dk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4571-6822</contrib-id><name name-style="western"><surname>Brogaard</surname><given-names initials="L">Louise</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4874-0174</contrib-id><name name-style="western"><surname>Jessen</surname><given-names initials="EE">Eline E.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jensen</surname><given-names initials="TK">Tim K.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Goletz</surname><given-names initials="S">Steffen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4506-4932</contrib-id><name name-style="western"><surname>Heegaard</surname><given-names initials="PMH">Peter M. H.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Skovgaard</surname><given-names initials="K">Kerstin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04qtj9h94</institution-id><institution-id institution-id-type="GRID">grid.5170.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 8870</institution-id><institution>Department of Biotechnology and Biomedicine, </institution><institution>Technical University of Denmark, </institution></institution-wrap>Kongens Lyngby, Denmark </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/035b05819</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Department of Veterinary and Animal Sciences, </institution><institution>University of Copenhagen, </institution></institution-wrap>Frederiksberg, Denmark </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04qtj9h94</institution-id><institution-id institution-id-type="GRID">grid.5170.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 8870</institution-id><institution>Department of Health Technology, </institution><institution>Technical University of Denmark, </institution></institution-wrap>Kongens Lyngby, Denmark </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00v807439</institution-id><institution-id institution-id-type="GRID">grid.489335.0</institution-id><institution-id institution-id-type="ISNI">0000000406180938</institution-id><institution>Present Address: Mater Research Institute&#8211;University of Queensland, </institution><institution>Translational Research Institute, </institution></institution-wrap>Woolloongabba, Queensland Australia </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>54</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496086</issue-id><fpage>238</fpage><lpage>246</lpage><history><date date-type="received"><day>12</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>4</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="41684_2025_Article_1588.pdf"/><abstract id="Abs1"><p id="Par1">Meta-inflammation (chronic, low-grade systemic inflammation) is increasingly recognized as an essential link between obesity and the development of various noncommunicable diseases. However, large animal models for studying obesity-related meta-inflammation are lacking. Minipigs have great potential as models for human diseases, warranting investigation of the performance of the G&#246;ttingen minipig as a model for obesity-associated meta-inflammation. Here, we fed 26 pigs a high-fat, fructose and cholesterol diet (HFFC) or a standard diet (SD) for 103&#8201;days, resulting in the HFFC group having a 45% higher body weight and 16% larger abdominal circumference by the end of the experiment. Meta-inflammation was shown in the HFFC group by elevated serum concentrations of the acute phase protein C-reactive protein for more than 60&#8201;days during development of obesity, accompanied by increased numbers of circulating neutrophils and monocytes. Additional obesity-related abnormalities included dyslipidemia, hepatosteatosis and transcriptional changes to genes related to inflammation and metabolism in circulating leukocytes, liver and visceral adipose tissue. Notably, the transcription of genes related to lipid metabolism, namely ATP-binding cassette subfamily A member 1 (<italic toggle="yes">ABCA1</italic>) and ATP-binding cassette subfamily G member 1 (<italic toggle="yes">ABCG1</italic>), was elevated in liver, visceral adipose tissue and circulating leukocytes (<italic toggle="yes">ABCA1</italic> only) in the HFFC group compared with the SD group. The development of obesity was accompanied by endotoxemia, indicated by a 2.5-fold increase in serum lipopolysaccharide concentration in the HFFC group compared with the SD group, suggesting increased intestinal permeability. In conclusion, the described G&#246;ttingen minipig model convincingly links diet-induced obesity, meta-inflammation and endotoxemia, achieved by short-duration HFFC dieting.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">The Article describes a minipig model of obesity-associated meta-inflammation, characterized by increased C-reactive protein levels and white blood cells, together with changes in the expression of genes related to inflammation and metabolism.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Obesity</kwd><kwd>Experimental models of disease</kwd><kwd>Chronic inflammation</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100008393</institution-id><institution>Teknologi og Produktion, Det Frie Forskningsr&#229;d (Technology and Production, Danish Council for Independent Research)</institution></institution-wrap></funding-source><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><award-id>3105-00073B</award-id><principal-award-recipient><name name-style="western"><surname>Starb&#230;k</surname><given-names>Sofie M. R.</given-names></name><name name-style="western"><surname>Henriksen</surname><given-names>Betina L.</given-names></name><name name-style="western"><surname>Brogaard</surname><given-names>Louise</given-names></name><name name-style="western"><surname>Jessen</surname><given-names>Eline E.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>Tim K.</given-names></name><name name-style="western"><surname>Goletz</surname><given-names>Steffen</given-names></name><name name-style="western"><surname>Heegaard</surname><given-names>Peter M. H.</given-names></name><name name-style="western"><surname>Skovgaard</surname><given-names>Kerstin</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden (Novo Nordisk Foundation)</institution></institution-wrap></funding-source><award-id>NNF19OC0056326</award-id><award-id>NNF19OC0056326</award-id><award-id>NNF19OC0056326</award-id><award-id>NNF19OC0056326</award-id><award-id>NNF19OC0056326</award-id><award-id>NNF19OC0056326</award-id><award-id>NNF19OC0056326</award-id><principal-award-recipient><name name-style="western"><surname>Starb&#230;k</surname><given-names>Sofie M. R.</given-names></name><name name-style="western"><surname>Brogaard</surname><given-names>Louise</given-names></name><name name-style="western"><surname>Jessen</surname><given-names>Eline E.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>Tim K.</given-names></name><name name-style="western"><surname>Goletz</surname><given-names>Steffen</given-names></name><name name-style="western"><surname>Heegaard</surname><given-names>Peter M. H.</given-names></name><name name-style="western"><surname>Skovgaard</surname><given-names>Kerstin</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature America, Inc. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Main</title><p id="Par3">Chronic low-grade systemic inflammation associated with metabolic disorders, known as meta-inflammation<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, is a common feature of obesity associated with a range of noncommunicable diseases, including cardiovascular diseases, type 2 diabetes, chronic respiratory diseases and cancers<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Prominent risk factors for these conditions include abdominal obesity and elevated levels of triglycerides, both key criterions of metabolic syndrome<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Furthermore, meta-inflammation increases the risk of severe infectious diseases, including COVID-19 and influenza<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. The underlying mechanisms of how meta-inflammation develops and how it is linked to disease severity are not fully understood, stressing the need for better, highly translational animal models reproducing obesity-driven meta-inflammation.</p><p id="Par4">Meta-inflammation can be characterized by a persistent increase in circulating levels of the acute-phase protein (APP) C-reactive protein (CRP) and white blood cells such as neutrophils<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref></sup>. Meta-inflammation can be caused by high intake of fat, cholesterol and sugars, leading to adipocyte hypertrophy, which in turn triggers immune cell infiltration and the secretion of pro-inflammatory adipokines<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. In addition, ectopic lipid accumulation in nonadipose tissues, such as the liver, can potentially lead to lipotoxicity<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. Furthermore, energy-dense diets can result in intestinal dysbiosis, which may increase intestinal permeability, allowing the leakage of endotoxins, predominantly lipopolysaccharides (LPS), into systemic circulation, causing endotoxemia<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. The passage of these harmful substances into the bloodstream, known as &#8216;leaky gut&#8217; syndrome, can trigger chronic inflammation<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. However, the causal relation between obesity, leaky gut and meta-inflammation remains poorly understood.</p><p id="Par5">Large animal models, such as the pig, show high translational relevance in the study of complex diseases. This includes the multifactorial condition of human obesity, associated meta-inflammation and obesity-related comorbidities<sup><xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref></sup>. The high translational value of pig models is rooted in their similar metabolism, gastrointestinal tract, cardiovascular system and proportionally similar organ size compared with humans<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. Pigs are prone to obesity and obesity-related comorbidities, and the G&#246;ttingen minipig is frequently used in biomedical research on obesity, metabolic syndrome and coronary vascular disease such as atherosclerosis. However, meta-inflammation associated with diet-induced obesity is not well characterized in porcine models. Although obesity can be induced in G&#246;ttingen minipigs by ad libitum feeding on a standard diet (SD)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, this approach has not resulted in meta-inflammation<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>. In some studies, feeding a more energy-dense diet for &gt;5&#8201;months resulted in elevated levels of pro-inflammatory cytokines and APPs in minipig models<sup><xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref></sup>. However, none of these studies reported the levels of these and other inflammatory markers in circulation continuously throughout the development of diet-induced obesity.</p><p id="Par6">The aim of the present study was to establish, characterize and evaluate the G&#246;ttingen minipig as a novel large animal model for diet-induced meta-inflammation using a Western-like diet high in fat, fructose and cholesterol. This study demonstrates long-term increased CRP and LPS concentrations in circulation, accompanied by changes in the expression of relevant genes in circulating leukocytes during the development of obesity, and in the liver and visceral adipose tissue (VAT) at termination, suggesting a chronic systemic inflammatory state in this large animal model. These findings support the use of pigs as the state-of-the-art model for human obesity and its comorbidities.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Steady increase in body weight and abdominal body circumference during the dieting period</title><p id="Par7">Twenty-six castrated male G&#246;ttingen minipigs, 9&#8211;10&#8201;weeks of age, were divided into two groups. One group received a diet high in fat, fructose and cholesterol (HFFC; <italic toggle="yes">n</italic>&#8201;=&#8201;13), and the other group received a SD (<italic toggle="yes">n</italic>&#8201;=&#8201;13) for 103&#8201;days (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>Experimental setup.</title><p>Twenty-six G&#246;ttingen minipigs were divided into two equal groups and fed either the HFFC diet (<italic toggle="yes">n</italic>&#8201;=&#8201;13) or the SD diet (<italic toggle="yes">n</italic>&#8201;=&#8201;13) for 103&#8201;days. Blood samples were collected from all animals throughout the study. CRP concentrations were quantified on days 0, 20, 41, 62, 83 and 98. Lipid concentrations were quantified on days 0, 62, 83 and 98. White blood cell counts were performed on days 0 and 98. LPS concentrations were quantified on day 99. Gene expression in circulating leukocytes was quantified on days 0, 20, 41, 62, 83 and 98. Gene expression in liver tissue and VAT was quantified in four randomly selected pigs from each diet group on day 103. Created in BioRender. Henriksen, B. (2025) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/25rsuz8">https://BioRender.com/25rsuz8</ext-link>.</p></caption><graphic id="d33e391" position="float" orientation="portrait" xlink:href="41684_2025_1588_Fig1_HTML.jpg"/></fig></p><p id="Par8">Body weight (BW) and abdominal circumference (ABC) increased steadily in both groups; however, the increase was accelerated in the HFFC group (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), demonstrating an obesogenic effect of the HFFC diet in G&#246;ttingen minipigs. From day 49 days and onward, both BW and ABC were significantly higher in the HFFC group compared with the SD group (BW: <italic toggle="yes">P</italic>&#8201;=&#8201;0.002; ABC: <italic toggle="yes">P</italic>&#8201;=&#8201;8.5&#8201;&#215;&#8201;10<sup>&#8722;7</sup>, two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests with Benjamini&#8211;Hochberg corrections) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). After 98&#8201;days, the average BW and ABC in the HFFC group were 45% and 16% higher than in the SD group, respectively. A slightly but significantly (<italic toggle="yes">P</italic>&#8201;=&#8201;0.014) lower ABC was initially observed in the HFFC group as the pigs adjusted to the new diet.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>The HFFC diet induces an increase in BW and ABC in G&#246;ttingen minipigs.</title><p>From day 49 of the study, significantly increased BWs (left <italic toggle="yes">y</italic> axis) and ABC (right <italic toggle="yes">y</italic> axis) were observed in the HFFC group compared with the SD group. Statistical significance of differences between the HFFC (<italic toggle="yes">n</italic>&#8201;=&#8201;13) and SD (<italic toggle="yes">n</italic>&#8201;=&#8201;13) groups was determined with Welch&#8217;s <italic toggle="yes">t</italic>-test and Benjamini&#8211;Hochberg corrections (*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). Error bars show the s.e.m.</p></caption><graphic id="d33e448" position="float" orientation="portrait" xlink:href="41684_2025_1588_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec4"><title>The HFFC diet induces meta-inflammation in G&#246;ttingen minipigs</title><p id="Par9">The average serum concentration of classical inflammation biomarker CRP was significantly (<italic toggle="yes">P</italic>&#8201;=&#8201;8.6&#8201;&#215;&#8201;10<sup>&#8722;5</sup>, two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests with Benjamini&#8211;Hochberg corrections) increased in the HFFC group compared with the SD group already from day 20 and remained higher in this group for the rest of the experiment. On day 20, the average serum concentration of CRP was twice as high in the HFFC group compared with the SD group, and between day 62 and day 98, the difference ranged from approximately 5-fold to 11-fold (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). Technical issues with CRP quantification in samples from day 41 made results from this time point unreliable, and they were therefore discarded.<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>The HFFC diet is associated with increased CRP serum concentrations in G&#246;ttingen minipigs.</title><p>Statistical significance of differences between the HFFC (<italic toggle="yes">n</italic>&#8201;=&#8201;13) and SD (<italic toggle="yes">n</italic>&#8201;=&#8201;13) groups was determined with Welch&#8217;s <italic toggle="yes">t</italic>-test and Benjamini&#8211;Hochberg corrections (**<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). The bars and error bars represent the mean and s.e.m.</p></caption><graphic id="d33e487" position="float" orientation="portrait" xlink:href="41684_2025_1588_Fig3_HTML.jpg"/></fig></p><p id="Par10">No difference in the number of circulating immune cells was observed between the dieting groups before initiation of the dieting regime; however, on day 98, the number of circulating neutrophils and monocytes in the HFFC group was approximately twice as high compared with the SD group (Fig. <xref rid="Fig4" ref-type="fig">4a,b</xref>).<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>The HFFC diet induces changes to circulating leukocytes and leads to endotoxemia and dyslipidemia.</title><p><bold>a</bold>, Circulating neutrophil counts. <bold>b</bold>, Circulating monocyte counts. <bold>c</bold>, Serum LPS concentration (in endotoxin units (EU)) on day 99 after initiation of diet regimes. <bold>d</bold>, Circulating triglyceride concentrations. <bold>e</bold>, Circulating total cholesterol concentration. <bold>f</bold>, Circulating LDL concentrations. <bold>g</bold>, Circulating HDL concentrations. Statistical significance of differences between cell counts and lipid concentrations in the HFFC (<italic toggle="yes">n</italic>&#8201;=&#8201;13) and SD (<italic toggle="yes">n</italic>&#8201;=&#8201;13) group was determined using Welch&#8217;s <italic toggle="yes">t</italic>-test with Benjamini&#8211;Hochberg corrections applied for multiple testing (**<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). Bars and error bars show the mean and s.e.m.</p></caption><graphic id="d33e537" position="float" orientation="portrait" xlink:href="41684_2025_1588_Fig4_HTML.jpg"/></fig></p><p id="Par11">To identify a possible cause of meta-inflammation, the serum concentration of LPS was measured on day 99. The serum LPS concentration was found to be significantly (<italic toggle="yes">P</italic>&#8201;=&#8201;4.4&#8201;&#215;&#8201;10<sup>&#8722;7</sup>, two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests with Benjamini&#8211;Hochberg corrections) elevated in the HFFC group, almost 2.5 times higher than in the SD group (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). Furthermore, a significant (<italic toggle="yes">P</italic>&#8201;=&#8201;0.02, Spearman&#8217;s correlation coefficient) positive correlation was observed between serum CRP and LPS concentrations (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Correlation between CRP concentration and anthropometric and biochemical parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="12" rowspan="1">CRP concentration</th></tr><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Day 0</th><th colspan="2" rowspan="1">Day 20</th><th colspan="2" rowspan="1">Day 62</th><th colspan="2" rowspan="1">Day 83</th><th colspan="2" rowspan="1">Day 98</th><th colspan="2" rowspan="1">Overall</th></tr><tr><th colspan="1" rowspan="1"><italic toggle="yes">r</italic><sub>S</sub></th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic></th><th colspan="1" rowspan="1"><italic toggle="yes">r</italic><sub>S</sub></th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic></th><th colspan="1" rowspan="1"><italic toggle="yes">r</italic><sub>S</sub></th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic></th><th colspan="1" rowspan="1"><italic toggle="yes">r</italic><sub>S</sub></th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic></th><th colspan="1" rowspan="1"><italic toggle="yes">r</italic><sub>S</sub></th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic></th><th colspan="1" rowspan="1"><italic toggle="yes">r</italic><sub>S</sub></th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><bold>BW</bold></td><td colspan="1" rowspan="1">0.38*</td><td colspan="1" rowspan="1">0.04</td><td colspan="1" rowspan="1">&#8722;0.08</td><td colspan="1" rowspan="1">0.67</td><td colspan="1" rowspan="1">0.71*</td><td colspan="1" rowspan="1">6.04 &#215; 10<sup>&#8722;6</sup></td><td colspan="1" rowspan="1">0.71*</td><td colspan="1" rowspan="1">5.62 &#215; 10<sup>&#8722;6</sup></td><td colspan="1" rowspan="1">0.73*</td><td colspan="1" rowspan="1">2.75 &#215; 10<sup>&#8722;6</sup></td><td colspan="1" rowspan="1">0.16*</td><td colspan="1" rowspan="1">0.03</td></tr><tr><td colspan="1" rowspan="1"><bold>ABC</bold></td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8722;0.02</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">0.80*</td><td colspan="1" rowspan="1">3.44 &#215; 10<sup>&#8722;8</sup></td><td colspan="1" rowspan="1">0.75*</td><td colspan="1" rowspan="1">8.59 &#215; 10<sup>&#8722;7</sup></td><td colspan="1" rowspan="1">0.65*</td><td colspan="1" rowspan="1">6.61 &#215; 10<sup>&#8722;5</sup></td><td colspan="1" rowspan="1">0.38*</td><td colspan="1" rowspan="1">1.10 &#215; 10<sup>&#8722;6</sup></td></tr><tr><td colspan="1" rowspan="1"><bold>LPS conc</bold>.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.48*</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1"><bold>Triglyceride conc</bold>.</td><td colspan="1" rowspan="1">0.11</td><td colspan="1" rowspan="1">0.62</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.70*</td><td colspan="1" rowspan="1">7.45 &#215; 10<sup>&#8722;5</sup></td><td colspan="1" rowspan="1">0.62*</td><td colspan="1" rowspan="1">7.39 &#215; 10<sup>&#8722;4</sup></td><td colspan="1" rowspan="1">0.61*</td><td colspan="1" rowspan="1">9.34 &#215; 10<sup>&#8722;4</sup></td><td colspan="1" rowspan="1">0.57*</td><td colspan="1" rowspan="1">2.77 &#215; 10<sup>&#8722;10</sup></td></tr><tr><td colspan="1" rowspan="1"><bold>Total cholesterol conc</bold>.</td><td colspan="1" rowspan="1">0.51*</td><td colspan="1" rowspan="1">0.01</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.77*</td><td colspan="1" rowspan="1">5.80 &#215; 10<sup>&#8722;6</sup></td><td colspan="1" rowspan="1">0.70*</td><td colspan="1" rowspan="1">7.74 &#215; 10<sup>&#8722;5</sup></td><td colspan="1" rowspan="1">0.70*</td><td colspan="1" rowspan="1">5.98 &#215; 10<sup>&#8722;5</sup></td><td colspan="1" rowspan="1">0.76*</td><td colspan="1" rowspan="1">6.09 &#215; 10<sup>&#8722;20</sup></td></tr><tr><td colspan="1" rowspan="1"><bold>LDL conc</bold>.</td><td colspan="1" rowspan="1">0.17</td><td colspan="1" rowspan="1">0.43</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.66*</td><td colspan="1" rowspan="1">2.24 &#215; 10<sup>&#8722;4</sup></td><td colspan="1" rowspan="1">0.68*</td><td colspan="1" rowspan="1">1.29 &#215; 10<sup>&#8722;4</sup></td><td colspan="1" rowspan="1">0.75*</td><td colspan="1" rowspan="1">1.10 &#215; 10<sup>&#8722;5</sup></td><td colspan="1" rowspan="1">0.70*</td><td colspan="1" rowspan="1">4.64 &#215; 10<sup>&#8722;16</sup></td></tr><tr><td colspan="1" rowspan="1"><bold>HDL conc</bold>.</td><td colspan="1" rowspan="1">0.36</td><td colspan="1" rowspan="1">0.09</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.09</td><td colspan="1" rowspan="1">0.66</td><td colspan="1" rowspan="1">&#8722;0.32</td><td colspan="1" rowspan="1">0.11</td><td colspan="1" rowspan="1">&#8722;0.25</td><td colspan="1" rowspan="1">0.21</td><td colspan="1" rowspan="1">&#8722;0.08</td><td colspan="1" rowspan="1">0.44</td></tr></tbody></table><table-wrap-foot><p>Statistically significant Spearman&#8217;s correlations (<italic toggle="yes">r</italic><sub>S</sub>) are indicated by an asterisk. <italic toggle="yes">P</italic>, <italic toggle="yes">P</italic> value; conc., concentration.</p></table-wrap-foot></table-wrap></p><p id="Par12">The HFFC diet induced dyslipidemia, indicated by significantly higher concentrations of triglycerides (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;8.8&#8201;&#215;&#8201;10<sup>&#8722;5</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0002; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.005, two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests with Benjamini&#8211;Hochberg correction), total cholesterol (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;6.1&#8201;&#215;&#8201;10<sup>&#8722;13</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;1.4&#8201;&#215;&#8201;10<sup>&#8722;11</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;2.5&#8201;&#215;&#8201;10<sup>&#8722;9</sup>) and low-density lipoprotein (LDL) (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;5.8&#8201;&#215;&#8201;10<sup>&#8722;8</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;8.5&#8201;&#215;&#8201;10<sup>&#8722;8</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;1.5&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) in the HFFC group compared with the SD group at all sampled time points after the diet period was initiated (days 62, 83 and 98) (Fig. <xref rid="Fig4" ref-type="fig">4d&#8211;f</xref>), whereas high-density lipoprotein (HDL) concentrations remained unchanged in both groups throughout the study (Fig. <xref rid="Fig4" ref-type="fig">4g</xref>). From day 62 onward, a significant positive correlation was observed between CRP and total cholesterol concentrations (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;5.8&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;7.7&#8201;&#215;&#8201;10<sup>&#8722;5</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;6.0&#8201;&#215;&#8201;10<sup>&#8722;5</sup>; Spearman&#8217;s rank correlation), between CRP and LDL concentrations (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;2.2&#8201;&#215;&#8201;10<sup>&#8722;4</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;1.3&#8201;&#215;&#8201;10<sup>&#8722;4</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;1.1&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), as well as between CRP and triglyceride concentrations (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;7.5&#8201;&#215;&#8201;10<sup>&#8722;5</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;7.4&#8201;&#215;&#8201;10<sup>&#8722;4</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;9.3&#8201;&#215;&#8201;10<sup>&#8722;4</sup>) (Table <xref rid="Tab1" ref-type="table">1</xref>). Significant positive correlations were also found between CRP concentration and BW (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;6.0&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;5.6&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;2.8&#8201;&#215;&#8201;10<sup>&#8722;6</sup>), as well as between CRP concentration and ABC (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;3.4&#8201;&#215;&#8201;10<sup>&#8722;8</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;8.6&#8201;&#215;&#8201;10<sup>&#8722;7</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;6.6&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), from day 62 onward (Table <xref rid="Tab1" ref-type="table">1</xref>).</p></sec><sec id="Sec5"><title>The HFFC diet induces changes to gene expression in VAT and circulating leukocytes</title><p id="Par13">Gene expression analysis and histopathological examination of VAT was performed on four randomly selected animals from each of the two diet groups at termination of the experiment. Gene expression results for all genes quantified in VAT can be found in Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>, while results for selected genes are presented in Table <xref rid="Tab2" ref-type="table">2</xref>. In line with the observed dyslipidemia in the HFFC group, two genes encoding proteins associated with uptake of lipids and cholesterol, ATP-binding cassette subfamily A member 1 (<italic toggle="yes">ABCA1</italic>) and ATP-binding cassette subfamily G member 1 (<italic toggle="yes">ABCG1</italic>), were upregulated in the VAT of the HFFC group compared with the SD group, as was the expression of the appetite regulator leptin (<italic toggle="yes">LEP</italic>) (Table <xref rid="Tab2" ref-type="table">2</xref>). Important genes associated with inflammation were upregulated in VAT in the HFFC group including interleukin (IL)-1&#945; (<italic toggle="yes">IL1A</italic>), interferon-&#947; (<italic toggle="yes">IFNG</italic>) and the positive APPs orosomucoid 1 (<italic toggle="yes">ORM1</italic>) and lactotransferrin (<italic toggle="yes">LTF</italic>), whereas the gene expression of pro-inflammatory cytokines <italic toggle="yes">IL6</italic> and tumor necrosis factor (<italic toggle="yes">TNF</italic>) was not affected by the HFFC diet (Table <xref rid="Tab2" ref-type="table">2</xref>). Transthyretin (<italic toggle="yes">TTR</italic>), recognized as a negative APP, and the anti-inflammatory interleukin 1 receptor antagonist (<italic toggle="yes">IL1RN</italic>) were downregulated in the HFFC group relative to the SD group, further indicating an altered inflammatory environment in the VAT of the HFFC group. In contrast to the expectations, the conventionally negative APP albumin (<italic toggle="yes">ALB</italic>), was more highly expressed in the HFFC group than in the SD group. Consistent with its role as a positive APP and the elevated concentrations of LPS in circulation, LPS-binding protein (<italic toggle="yes">LBP</italic>) was also upregulated in the HFFC group. In agreement with histopathological examination of VAT from pigs in the HFFC group (data not shown), which revealed no sign of neutrophil or monocyte infiltration, there was no observed increase in the gene expression of relevant cellular markers (cluster of differentiation (<italic toggle="yes">CD</italic>) <italic toggle="yes">68</italic>, <italic toggle="yes">CD163</italic>, <italic toggle="yes">CD80</italic> and <italic toggle="yes">CD86</italic>)).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Gene expression in VAT</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Gene</th><th colspan="2" rowspan="1">VAT relative expression level&#8201;&#177;&#8201;s.e.m.</th></tr><tr><th colspan="1" rowspan="1">SD group</th><th colspan="1" rowspan="1">HFFC group</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><italic toggle="yes">LTF</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">9.9&#8201;&#177;&#8201;2.8</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ABCA1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">4.7&#8201;&#177;&#8201;1.0</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">LEP</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">3.2&#8201;&#177;&#8201;0.8</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ABCG1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">2.9&#8201;&#177;&#8201;0.6</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">LBP</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.5</td><td colspan="1" rowspan="1">2.6&#8201;&#177;&#8201;0.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">IL1A</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">2.6&#8201;&#177;&#8201;0.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">IFNG</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">2.3&#8201;&#177;&#8201;0.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ORM1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">2.2&#8201;&#177;&#8201;0.5</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ALB</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">2.0&#8201;&#177;&#8201;0.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD80</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">1.4&#8201;&#177;&#8201;0.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CXCL8</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">1.2&#8201;&#177;&#8201;0.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD68</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.4</td><td colspan="1" rowspan="1">1.2&#8201;&#177;&#8201;0.1</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">TNF</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">1.1&#8201;&#177;&#8201;0.5</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">IL6</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">1.1&#8201;&#177;&#8201;0.2</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD163</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.4</td><td colspan="1" rowspan="1">1.1&#8201;&#177;&#8201;0.2</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">SAA3</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">0.9&#8201;&#177;&#8201;0.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD86</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.4</td><td colspan="1" rowspan="1">0.8&#8201;&#177;&#8201;0.1</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">IL1RN</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.4</td><td colspan="1" rowspan="1">0.5&#8201;&#177;&#8201;0.1</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CXCL14</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">0.5&#8201;&#177;&#8201;0.0</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">TTR</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.9</td><td colspan="1" rowspan="1">0.2&#8201;&#177;&#8201;0.1</td></tr></tbody></table><table-wrap-foot><p>Mean gene expression in the SD group (<italic toggle="yes">n</italic>&#8201;=&#8201;3) is scaled to 1, and mean gene expression in the HFFC group (<italic toggle="yes">n</italic>&#8201;=&#8201;4) is shown relative to the SD group. Results are presented as group means&#8201;&#177;&#8201;s.e.m.</p></table-wrap-foot></table-wrap></p><p id="Par14">Analysis of gene expression in circulating leukocytes revealed that the HFFC diet resulted in significant upregulation of the inflammation-related genes <italic toggle="yes">LTF</italic> (day 20: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0004; day 41: <italic toggle="yes">P</italic>&#8201;=&#8201;0.007; day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;4.8&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;1.4&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.001, two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests on log<sub>2</sub>-transformed data with Benjamini&#8211;Hochberg correction), haptoglobin (<italic toggle="yes">HP</italic>) (day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;0.009; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;1.4&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.001), <italic toggle="yes">CD163</italic> (day 20: <italic toggle="yes">P</italic>&#8201;=&#8201;0.03; day 41: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0007; day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;4.79&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;5.02&#8201;&#215;&#8201;10<sup>&#8722;7</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.005), and S100 calcium-binding proteins A8 (<italic toggle="yes">S100A8</italic>) (day 20: <italic toggle="yes">P</italic>&#8201;=&#8201;0.003; day 41: <italic toggle="yes">P</italic>&#8201;=&#8201;0.03; day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0003; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0007; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.01) and A12 (<italic toggle="yes">S100A12</italic>) (day 20: <italic toggle="yes">P</italic>&#8201;=&#8201;0.008; day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;0.009; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0003; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.02) at most or all sampled time points after initiation of the dieting regime compared with the SD diet (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The classical pro-inflammatory cytokine <italic toggle="yes">IL6</italic> was significantly upregulated in the HFFC group only on day 83 (<italic toggle="yes">P</italic>&#8201;=&#8201;0.01), whereas expression of <italic toggle="yes">TNF</italic>, <italic toggle="yes">IL1A</italic> and C-X-C motif chemokine ligand 8 (<italic toggle="yes">CXCL8</italic>) was not different between the two diet groups in circulating leukocytes at any time point (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). In addition, the gene expression levels of the inflammatory matrix metallopeptidase 9 (<italic toggle="yes">MMP9</italic>) were significantly reduced in circulating leukocytes of the HFFC group compared with the SD group from day 41 onward (day 41: <italic toggle="yes">P</italic>&#8201;=&#8201;4.75&#8201;&#215;&#8201;10<sup>&#8722;5</sup>; day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;0.003; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;0.0002; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;0.005) (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Similar to VAT, expression of <italic toggle="yes">ABCA1</italic> was significantly upregulated in circulating leukocytes in the HFFC group from day 20 onward (day 20: <italic toggle="yes">P</italic>&#8201;=&#8201;9.56&#8201;&#215;&#8201;10<sup>&#8722;11</sup>; day 41: <italic toggle="yes">P</italic>&#8201;=&#8201;9.56&#8201;&#215;&#8201;10<sup>&#8722;11</sup>; day 62: <italic toggle="yes">P</italic>&#8201;=&#8201;9.56&#8201;&#215;&#8201;10<sup>&#8722;11</sup>; day 83: <italic toggle="yes">P</italic>&#8201;=&#8201;4.33&#8201;&#215;&#8201;10<sup>&#8722;6</sup>; day 98: <italic toggle="yes">P</italic>&#8201;=&#8201;1.85&#8201;&#215;&#8201;10<sup>&#8722;11</sup>) (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Gene expression results for all genes quantified in circulating leukocytes can be found in Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>.<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><title>The HFFC diet induces changes in gene expression in circulating leukocytes throughout the dieting period.</title><p>The expression of each gene is scaled to the expression level in the SD group on day 0. Statistical significance of differences between the HFFC (<italic toggle="yes">n</italic>&#8201;=&#8201;13) and SD (<italic toggle="yes">n</italic>&#8201;=&#8201;13) groups at individual time points was determined with Welch&#8217;s <italic toggle="yes">t</italic>-test and Benjamini&#8211;Hochberg corrections (*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). Bars and error bars show the mean and s.e.m.</p></caption><graphic id="d33e1555" position="float" orientation="portrait" xlink:href="41684_2025_1588_Fig5_HTML.jpg"/></fig></p></sec><sec id="Sec6"><title>The HFFC diet is associated with steatosis and differential gene expression in the liver</title><p id="Par15">Livers in all HFFC-fed pigs were pale and enlarged compared with livers in the SD-fed pigs (Fig. <xref rid="Fig6" ref-type="fig">6a</xref>). Histopathological examination revealed that livers of the SD-fed pigs showed normal parenchyma characterized by polygonal hepatocytes and visible sinusoidal spaces (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). A few hepatocytes with lipid vacuoles were seen in two out of four SD-fed pigs. In the HFFC-fed pigs, parenchyma was characterized by severe steatosis with swollen hepatocytes showing decreased stainability of the cytoplasm due to microvesicular lipids (Fig. <xref rid="Fig6" ref-type="fig">6c</xref>). In addition, large lipid droplet vacuolation was found in one of four livers (Fig. <xref rid="Fig6" ref-type="fig">6d</xref>). The increased size of the hepatocytes made it impossible to recognize the polygonal appearance and the contour of the sinusoidal space in the four HFFD animals. No immune cell infiltration was observed in either diet group, suggesting absence of inflammation in the liver.<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><title>Macroscopic and microscopic changes observed in livers of HFFC-fed pigs.</title><p><bold>a</bold>, Livers from pigs in the HFFC group displayed steatosis (right), while livers from pigs in the SD group were normal (left). Histopathological examination was performed on pigs from both the HFFC (<italic toggle="yes">n</italic>&#8201;=&#8201;4) and SD (<italic toggle="yes">n</italic>&#8201;=&#8201;4) groups. <bold>b</bold>, Histological analysis of the liver from an SD-fed pig. Arrowheads, sinusoidal space; star, central vein; arrow, portal arteriole. <bold>c</bold>, Liver from HFFC-fed pig. Arrowheads, microvesicular lipids; star, central vein; arrow, portal arteriole. <bold>d</bold>, Liver from HFFC-fed pig. Arrowheads, large lipid vacuoles; star, central vein; arrow: portal arteriole. Scale bars, 200&#8201;&#181;m (<bold>b</bold>&#8211;<bold>d</bold>).</p></caption><graphic id="d33e1604" position="float" orientation="portrait" xlink:href="41684_2025_1588_Fig6_HTML.jpg"/></fig></p><p id="Par16">Gene expression results for all genes quantified in the liver can be found in Supplementary Table <xref rid="MOESM1" ref-type="media">3</xref>. Gene expression results for selected genes are presented in Table <xref rid="Tab3" ref-type="table">3</xref>. Surprisingly, the expression of <italic toggle="yes">CRP</italic> and other APPs including <italic toggle="yes">HP</italic> and <italic toggle="yes">ORM1</italic>, was not upregulated in the livers of HFFC-fed pigs but rather tended to be downregulated compared with SD-fed pigs (Table <xref rid="Tab3" ref-type="table">3</xref>). However, several other genes involved in tissue inflammation, including serum amyloid A3 (<italic toggle="yes">SAA3</italic>), <italic toggle="yes">LTF</italic>, <italic toggle="yes">TNF</italic>, <italic toggle="yes">IL1A</italic>, <italic toggle="yes">IFNG</italic>, <italic toggle="yes">S100A8</italic>, <italic toggle="yes">S100A12</italic>, <italic toggle="yes">MMP9</italic>, C-C motif chemokine ligand 3 and 4 (<italic toggle="yes">CCL3</italic> and <italic toggle="yes">CCL4</italic>), <italic toggle="yes">CXCL8</italic>, <italic toggle="yes">CXCL10</italic>, <italic toggle="yes">CXCL14</italic>, secreted phosphoprotein 1 (<italic toggle="yes">SPP1</italic>) and C-X-C motif chemokine receptor 4 (<italic toggle="yes">CXCR4</italic>), were expressed at higher levels in the livers of the HFFC group compared with the SD group (Table <xref rid="Tab3" ref-type="table">3</xref>). In contrast to expression patterns observed in the VAT, the genes encoding the dendritic cell, monocyte and macrophage markers <italic toggle="yes">CD68</italic>, <italic toggle="yes">CD80</italic> and <italic toggle="yes">CD86</italic> were upregulated in livers of the HFFC group, whereas the expression of the tissue-resident macrophage marker <italic toggle="yes">CD163</italic> was unchanged in the HFFC-fed pigs compared with the SD-fed pigs. In agreement with the expression signatures in VAT, <italic toggle="yes">ABCA1</italic> and <italic toggle="yes">ABCG1</italic> were upregulated in livers of the HFFC group compared with the SD group, which was also the case for other genes involved in fatty acid metabolism associated with high uptake of lipids and cholesterol, such as <italic toggle="yes">CD36</italic>, peroxisome proliferator activated receptor gamma (<italic toggle="yes">PPARG</italic>) and stearoyl-CoA desaturase (<italic toggle="yes">SCD</italic>), the latter of which was downregulated in VAT of the HFFC group. By contrast, hepatic expression of the fatty acid synthase gene <italic toggle="yes">FASN</italic> tended to be downregulated. Klotho beta (<italic toggle="yes">KLB</italic>), encoding &#946;-klotho, serving as a co-receptor for fibroblast growth factor 21 involved in energy homeostasis, adipogenesis and bile acid production, was the most strongly downregulated gene in the livers of the HFFC group.<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Gene expression in the liver</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Gene</th><th colspan="2" rowspan="1">Liver relative expression level&#8201;&#177;&#8201;s.e.m.</th></tr><tr><th colspan="1" rowspan="1">SD group</th><th colspan="1" rowspan="1">HFFC group</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><italic toggle="yes">CXCL14</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">113.6&#8201;&#177;&#8201;25.8</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">PPARG</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">53.7&#8201;&#177;&#8201;11.5</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ABCG1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">35.8&#8201;&#177;&#8201;4.0</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">SAA3</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.4</td><td colspan="1" rowspan="1">27.8&#8201;&#177;&#8201;13.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">MMP9</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.5</td><td colspan="1" rowspan="1">20.2&#8201;&#177;&#8201;11.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">SPP1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">13.0&#8201;&#177;&#8201;2.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD36</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">7.7&#8201;&#177;&#8201;2.2</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD68</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">7.3&#8201;&#177;&#8201;1.7</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CXCL8</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">6.6&#8201;&#177;&#8201;1.9</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">S100A8</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">6.3&#8201;&#177;&#8201;0.8</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CXCL10</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.4</td><td colspan="1" rowspan="1">6.2&#8201;&#177;&#8201;2.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CXCR4</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">6.0&#8201;&#177;&#8201;1.8</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD86</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">5.6&#8201;&#177;&#8201;0.5</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">LTF</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">4.0&#8201;&#177;&#8201;1.1</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CCL3</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">3.8&#8201;&#177;&#8201;0.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">S100A12</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">3.8&#8201;&#177;&#8201;0.5</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CD80</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">3.4&#8201;&#177;&#8201;0.8</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">NOS2</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">3.2&#8201;&#177;&#8201;0.7</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">IFNG</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">3.0&#8201;&#177;&#8201;0.6</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ABCA1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">2.8&#8201;&#177;&#8201;0.3</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">TNF</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">2.5&#8201;&#177;&#8201;0.5</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">SCD</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">2.4&#8201;&#177;&#8201;0.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">CCL4</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">2.2&#8201;&#177;&#8201;0.4</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">IL1A</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.1</td><td colspan="1" rowspan="1">2.2&#8201;&#177;&#8201;1.0</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">HP</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">0.5&#8201;&#177;&#8201;0.2</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">ORM1</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">0.5&#8201;&#177;&#8201;0.04</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">FASN</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.2</td><td colspan="1" rowspan="1">0.3&#8201;&#177;&#8201;0.1</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">KLB</italic></td><td colspan="1" rowspan="1">1&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">0.009&#8201;&#177;&#8201;0.004</td></tr></tbody></table><table-wrap-foot><p>Mean gene expression in the SD group (<italic toggle="yes">n</italic>&#8201;=&#8201;4) is scaled to 1, and mean gene expression in the HFFC group (<italic toggle="yes">n</italic>&#8201;=&#8201;4) is shown relative to the SD group. Results are presented as group means&#8201;&#177;&#8201;s.e.m.</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p id="Par17">We successfully induced a state of obesity and meta-inflammation in castrated male G&#246;ttingen minipigs by feeding them a Western-like HFFC diet. The presence of meta-inflammation was confirmed by consistently elevated serum CRP concentrations from day 20 and substantiated by increased counts of circulating neutrophils and monocytes on day 98 compared with pigs fed the SD diet. This study continuously monitored and demonstrated long-term diet-induced increases in serum CRP concentrations, along with elevated serum LPS concentrations and increased expression of genes related to inflammation and metabolism in the VAT and liver. These findings align well with those observed in children and adults with obesity<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref></sup> who are at increased risk of diseases such as cardiovascular diseases and type 2 diabetes<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. The presence of meta-inflammation was indicated by differential expression of several genes such as <italic toggle="yes">LTF</italic>, <italic toggle="yes">S100A8</italic> and <italic toggle="yes">S100A12</italic>, associated with inflammation, and <italic toggle="yes">ABCA1</italic>, associated with lipid metabolism, not only in circulating leukocytes but also in VAT, liver tissue or both, in the obese HFFC-fed pigs compared with SD-fed pigs. Future validation of transcriptional results by protein quantification would further substantiate our findings.</p><p id="Par18">Several studies have used minipigs as obesity models using various HFFC-like diets to mimic a Western-like diet or simply using ad libitum feeding with a SD<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR34">34</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref></sup>. While obesity was achieved in all studies, the accompanying effects varied: some animals displayed dyslipidemia<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>, elevated serum CRP concentration or other inflammatory markers<sup><xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>, or varying degrees of hepatic inflammation<sup><xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>. The variations in these different studies may be attributed to differences in diet composition, pig breed and study duration. Sex may also affect the outcome, as it has been found to influence the ability to develop obesity, as has the sterilization status of the animal<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. To avoid this confounder, we used only castrated males; however, future studies would benefit from including female pigs as well. Although the G&#246;ttingen minipig is well characterized and widely used in studies of obesity and metabolic syndrome and has shown high translational value for these conditions in humans, the use of the Ossabaw minipig model might also be considered in future studies, as the model may produce results with even higher fidelity<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>.</p><p id="Par19">In the present study, all the responses commonly exhibited by obese individuals were observed. Given the importance of diet composition and study duration for inducing meta-inflammation, continuous measurements of inflammatory biomarkers, as performed in the present study, can enhance our understanding of the causality, dynamics and the potential development of tolerance to long-term inflammation and exposure to Western-like diets.</p><p id="Par20">In the present study, serum CRP concentrations were significantly higher in obese pigs compared with nonobese pigs from day 20, even though we observed no increase in expression of <italic toggle="yes">CRP</italic> in liver and VAT at the end of the study. Other studies have previously demonstrated that administering similar HFFC diets to minipigs for extended periods of time did not result in systemic inflammation at the end of the study despite the pigs developing obesity<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. In these studies, the duration of dieting was longer (24&#8201;weeks or 13&#8201;months, respectively) than the 14-week diet period of the present study. In addition, changes to CRP concentrations or other inflammatory markers were not continuously monitored in these two studies. In our HFFC group, CRP concentration continuously increased from day 0 to day 83, followed by a decline from day 83 to day 98, although it still remained significantly increased in the HFFC group compared with the SD group. This finding, taken together with the unchanged liver expression of <italic toggle="yes">CRP</italic>, may suggest that concentrations of circulating CRP in obese pigs could be leveling off toward the end of our experiment. These findings add a level of complexity to the understanding of underlying mechanisms of obesity, meta-inflammation and noncommunicable diseases.</p><p id="Par21">Although obesity is commonly thought to induce inflammation, we observed an increase in serum CRP concentration in the HFFC group 4&#8201;weeks before significant differences in BW were observed between the two diet groups. Several studies have suggested that obesity alone does not necessarily lead to increased concentrations of inflammatory markers in circulation<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. The present findings suggest that the diet, rather than obesity alone, may be an important contributor to the observed inflammatory state. Accordingly, no correlation was seen between CRP concentrations and BW or ABC on day 20, when CRP was already significantly elevated in the HFFC group. In addition to the evidence of inflammation provided by CRP concentrations, the significant increase in gene expression of inflammatory markers such as <italic toggle="yes">LTF</italic>, <italic toggle="yes">HP</italic>, <italic toggle="yes">S100A8</italic> and <italic toggle="yes">S100A12</italic> in leukocytes, already from day 20, emphasizes that a state of inflammation might precede the onset of significant weight gain.</p><p id="Par22">Meta-inflammation associated with obesity is considered to be of multifactorial origin. Although adipose tissue is often considered a key contributor, studies have suggested that bacterial components including LPS from a leaky gut may also have a role in inducing and sustaining systemic inflammation<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. Consumption of energy dense Western-like diets might result not only in adipose tissue expansion and dyslipidemia but also in increased concentrations of circulating LPS due to gut hyperpermeability, potentially related to microbiota dysbiosis that adversely affects gut barrier integrity<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Bacterial LPS may thus enter the bloodstream, contributing to systemic inflammation and potentially to metabolic changes, as observed both in the present study and in human studies<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. In the present study, LPS concentration in the serum from the HFFC pigs was almost 2.5 times higher than that in SD pigs, mirroring findings in obese mice and humans<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. Moreover, we observed a significant positive correlation between serum LPS and CRP concentrations, suggesting a potential role of endotoxemia in diet-induced meta-inflammation. However, as serum LPS concentrations were measured only at the end of the experiment, it can only be speculated whether elevated LPS concentrations also preceded the onset of obesity and thereby contributed to the early increase in serum CRP concentrations in the HFFC group. Whereas this would be in agreement with the elevated expression of the abovementioned inflammatory markers in circulating leukocytes throughout the experiment (for example, LTF and S100A8), we found no or limited increase in expression of pro-inflammatory genes <italic toggle="yes">IL1A</italic>, <italic toggle="yes">IL6</italic>, <italic toggle="yes">TNF</italic> and <italic toggle="yes">CXCL8</italic> in leukocytes. Along with endotoxemia, dyslipidemia also showed a significant association with inflammation in our model. We observed consistent positive correlations between CRP concentrations and lipid parameters from day 62 onward, even as CRP concentrations declined. These associations suggest that both metabolic disturbances and endotoxemia may contribute to the inflammatory state in diet-induced obesity.</p><p id="Par23">Adipocyte hypertrophy and metabolic changes may lead to adipose tissue inflammation, causing adipocytes to secrete pro-inflammatory adipokines and chemokines. We observed that several genes centrally associated with inflammation, including <italic toggle="yes">IL1A</italic>, <italic toggle="yes">IFNG</italic> and APPs such as <italic toggle="yes">LTF</italic>, <italic toggle="yes">ORM1</italic> and <italic toggle="yes">ALB</italic>, contributed to an inflammatory gene expression signature in VAT of the obese pigs in the present study. Surprisingly, the expression of inflammatory cytokines such as <italic toggle="yes">TNF</italic>, <italic toggle="yes">IL6</italic> and <italic toggle="yes">CXCL8</italic> and the APP <italic toggle="yes">SAA3</italic> remained unchanged, resembling our observations in circulating leukocytes. In addition, histological examination of VAT from obese pigs showed no lymphocyte infiltration, and gene expression analysis indicated an unchanged expression of inflammatory cytokines and immune cell surface proteins, including <italic toggle="yes">CD68</italic>, <italic toggle="yes">CD80</italic> and <italic toggle="yes">CD86</italic>, with downregulation of the monocyte attractant chemokine <italic toggle="yes">CXCL14</italic>. This finding contrasts with human studies, which have reported increased expression of <italic toggle="yes">TNF</italic> and <italic toggle="yes">IL6</italic> in the adipose tissue of obese individuals<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. However, our observations align with a study using G&#246;ttingen minipigs fed a similar HFFC diet for 13&#8201;months, where no upregulation of inflammatory cytokines in VAT and no monocyte infiltration in the adipose tissues were observed<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. We found evidence in VAT of gene expression that may contribute to an anti-inflammatory effect in obese pigs, namely the upregulation of <italic toggle="yes">ABCA1</italic> and <italic toggle="yes">ABCG1</italic>, indicating diet-induced metabolic changes. ABCA1 and ABCG1 promote cholesterol and lipid efflux, mitigating inflammatory effects associated with obesity by maintaining the levels of anti-inflammatory HDL particles<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>. Our findings are consistent with findings from human and pig studies, showing increased mRNA levels of <italic toggle="yes">ABCA1</italic> and/or <italic toggle="yes">ABCG1</italic> in adipose tissue of obese participants<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>. Expression of <italic toggle="yes">ABCA1</italic> and <italic toggle="yes">ABCG1</italic> might have a role in balancing pro-inflammatory and anti-inflammatory processes during chronic inflammation, highlighting the interplay of metabolic and inflammatory pathways in achieving immune homeostasis in adipose tissue.</p><p id="Par24">The HFFC diet led to steatosis of the liver. Alterations to the hepatic lipid metabolism were evident from the increased expression of related genes, including <italic toggle="yes">ABCA1</italic>, <italic toggle="yes">ABCG1</italic>, <italic toggle="yes">PPARG</italic> and <italic toggle="yes">CD36</italic>, whereas <italic toggle="yes">FASN</italic> was downregulated in obese pigs. <italic toggle="yes">KLB</italic>, associated with fatty acid oxidation and suppression of lipogenesis, was strongly downregulated in the livers of obese pigs in concordance with other studies<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. The reduction in <italic toggle="yes">KLB</italic> expression could enhance lipogenesis, potentially exacerbating lipotoxicity and inflammation within hepatocytes<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, as well as promote the observed development of liver steatosis in obese pigs<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Transcriptionally, the steatotic livers also showed indications of increased inflammation, with elevated expression of <italic toggle="yes">TNF</italic>, <italic toggle="yes">CXCL8</italic>, <italic toggle="yes">CXCL10</italic>, <italic toggle="yes">CXCL14</italic>, <italic toggle="yes">CXCR4</italic>, <italic toggle="yes">S100A8</italic>, <italic toggle="yes">S100A12</italic>, <italic toggle="yes">MMP9</italic>, <italic toggle="yes">SAA3</italic> and <italic toggle="yes">SPP1</italic>, all of which are involved in immune cell recruitment and infiltration. This is relevant as the association between liver steatosis and an inflammatory hepatic environment is well described<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>.</p><p id="Par25">In conclusion, we successfully established a minipig model for diet-induced obesity with accompanying meta-inflammation and endotoxemia, offering a valuable tool to enhance our understanding of the mechanisms linking obesity to its serious comorbidities. Meta-inflammation was confirmed through persistently elevated CRP serum concentrations, dyslipidemia, endotoxemia and increased circulating numbers of neutrophils and monocytes, along with upregulated expression of genes related to inflammation and metabolism in circulating leukocytes, the liver and adipose tissue. These findings further underline the multifactorial nature of diet-induced meta-inflammation. Beyond elucidating the connections between obesity, metabolic syndrome and cardiometabolic diseases, this animal model holds substantial relevance for exploring the role of meta-inflammation in exacerbating infectious diseases such as influenza and COVID-19. The model may also guide the development of improved therapeutics and vaccines against such infections in high-risk populations in the future.</p></sec><sec id="Sec8"><title>Methods</title><sec id="Sec9"><title>Animals and diets</title><p id="Par26">The study was approved by the Animal Experiments Inspectorate, Ministry of Justice, Denmark (permit number 2016-15-0201-01022). Nine-week-old, castrated male G&#246;ttingen minipigs (<italic toggle="yes">n</italic>&#8201;=&#8201;26, based on statistical power calculation) (Ellegaard G&#246;ttingen Minipigs A/S) were housed on a 12-h light/12-h dark cycle with free access to water and were fed twice daily. Animals were randomized into two dietary groups (Fig. <xref rid="Fig1" ref-type="fig">1</xref>): a control group fed a standard minipig chow (Mini-pig, Special Diets Services, Supplementary Table <xref rid="MOESM1" ref-type="media">4</xref>) according to the breeder&#8217;s guidelines (SD group, <italic toggle="yes">n</italic>&#8201;=&#8201;13), and a group fed a diet high in fat, fructose and cholesterol (20,045&#8201;ppm) (Ossabaw pig diet &#8211; 5B4L, TestDiet, Supplementary Table <xref rid="MOESM1" ref-type="media">4</xref>) (HFFC group, <italic toggle="yes">n</italic>&#8201;=&#8201;13). The fat component of the HFFC diet was made up of 52.9% saturated fatty acids, 25.5% monounsaturated fatty acids, 8.5% polyunsaturated fatty acids and 13.1% other (by weight). Drinking water was freely available. The HFFC group was fed 2.5&#8211;3.0% of the average BW of the group and thus adjusted according to the weekly weighing. All animals were weighed weekly, and the ABC was measured at the umbilicus. Blood samples were collected on days 0, 20, 41, 62, 83, 98 and 99. On day 103, the animals were sedated by Zoletil and euthanized by intracardiac injection of pentobarbital. The animals were fasted for a minimum of 12&#8201;h before blood collection. Liver and VAT samples were collected for transcriptional analysis from eight randomly selected pigs (four from the SD group and four from the HFFC group).</p></sec><sec id="Sec10"><title>Sampling and handling of blood and tissue samples</title><p id="Par27">Blood samples were collected in PAXgene Blood RNA Tubes (PreAnalytiX), BD Vacutainer K<sub>3</sub>EDTA Tubes (BD Company) and BD Vacutainer Serum Tubes coated with silica (BD Company) at the time points indicated in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. After blood draw, tubes were inverted eight to ten times. PAXgene Blood RNA Tubes were stored at room temperature in an upright position for at least 2&#8201;h before storage at &#8722;20&#8201;&#176;C until RNA extraction. K<sub>3</sub>EDTA-coated tubes were stored on ice for 4&#8211;6&#8201;h and at 4&#8201;&#176;C until cell counting the following day. Serum tubes were stored at room temperature for 4&#8211;6&#8201;h before centrifugation at 1,200<italic toggle="yes">g</italic> for 10&#8201;min. Liver and VAT samples were collected at the end of the experiment and stored overnight in RNAlater (Thermo Fisher Scientific) at 4&#8201;&#176;C before transferring to &#8722;20&#8201;&#176;C until RNA extraction.</p></sec><sec id="Sec11"><title>CRP detection by ELISA</title><p id="Par28">CRP serum concentration was determined by dendrimer-coupled cytidine diphosphocholine indirect ELISA as described previously<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. The lower limit of detection was 1.42&#8201;mg/l.</p></sec><sec id="Sec12"><title>Biochemical analysis and white blood cell count</title><p id="Par29">Plasma concentrations of total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides, along with the white blood cell count, were determined using the Advia 1800 Chemistry System and appertaining reagents (Siemens) according to the manufacturer&#8217;s specifications at the Veterinary Diagnostic Laboratory at the University of Copenhagen, Denmark.</p></sec><sec id="Sec13"><title>RNA extraction from blood samples</title><p id="Par30">Total RNA was extracted from blood samples in PAXgene Blood RNA Tubes and treated with RNase-free DNase to remove genomic DNA (gDNA) using the PAXgene Blood miRNA Kit (PreAnalytix) according to the manufacturer&#8217;s specifications with the minor alteration of repeating the elution step by reusing the eluate. The process included on-column DNase treatment for elimination of gDNA. RNA quality was evaluated by the RNA integrity number (RIN) using the Agilent RNA 6000 Nano Kit on an Agilent 2100 Bioanalyzer (Agilent Technologies). The mean RIN was 8.2 (range 6.4&#8211;9.6).</p></sec><sec id="Sec14"><title>RNA extraction from liver and VAT</title><p id="Par31">Approximately 30&#8201;mg of liver tissue or VAT was homogenized in 1&#8201;ml QIAzol Lysis Reagent (Qiagen) using M-tubes and a gentleMACS Dissociator (Miltenyi Biotec) and afterward thoroughly mixed with 200&#8201;&#956;l chloroform (Emsure). From this point, total RNA was isolated according to the manufacturer&#8217;s instructions using the miRNeasy Mini Kit (Qiagen), including on-column DNase treatment for elimination of gDNA. The mean RIN for liver was 6.9 (range 6.0&#8211;7.9), while mean RIN for VAT was 8.1 (range 7.2&#8211;8.6).</p></sec><sec id="Sec15"><title>cDNA synthesis, preamplification and exonuclease treatment</title><p id="Par32">Complementary DNA (cDNA) was synthesized in two replicates from each sample of isolated RNA from liver, VAT and whole blood using 500&#8201;ng total RNA per reaction. The QuantiTect Reverse Transcription Kit (Qiagen) was used for cDNA synthesis, using an optimized version of the manufacturer&#8217;s instructions. Alterations to the manufacturer&#8217;s instructions included using 1.5&#8201;&#181;l gDNA Wipeout Buffer in the DNase treatment step and 0.75&#8201;&#956;l Quantiscript Reverse Transcriptase, 0.75&#8201;&#956;l RT Primer Mix and 3&#8201;&#956;l Quantiscript RT Buffer in the cDNA synthesis step. cDNA samples were preamplified by combining 3&#8201;&#956;l TaqMan PreAmp Master Mix (Applied Biosystems), 2.5&#8201;&#956;l 200&#8201;mM mix of specific primers (Supplementary Tables <xref rid="MOESM1" ref-type="media">5</xref> and <xref rid="MOESM1" ref-type="media">6</xref>) used in the subsequent quantitative PCR (qPCR), 2&#8201;&#956;l low-EDTA TE buffer, and 2.5&#8201;&#956;l diluted cDNA (1:10 in low-EDTA TE buffer (1&#215;) (PanReac AppliChem)) per reaction. The mix was incubated at 95&#8201;&#176;C for 10&#8201;min, followed by 19 cycles for blood samples and VAT and 18 cycles for liver samples of 95&#8201;&#176;C for 10&#8201;s and 60&#8201;&#176;C for 4&#8201;min. Preamplified cDNA was treated with 4&#8201;U Exonuclease I for 30&#8201;min at 37&#8201;&#176;C, followed by 80&#8201;&#176;C for 15&#8201;min, and diluted 1:10 in low-EDTA TE buffer before qPCR.</p></sec><sec id="Sec16"><title>qPCR</title><p id="Par33">qPCR was carried out in Dynamic Array Integrated Fluid Circuit (IFC) chips on a BioMark real-time PCR platform (Standard Biotools). Twenty genes of interest in addition to four potential reference genes (Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref>) were selected for quantification in all blood samples from days 0, 20, 41, 62, 83 and 98 on 192.24 Dynamic Array IFC chips for gene expression (Standard Biotools) on a BioMark real-time PCR platform (Standard Biotools) according to the manufacturer&#8217;s specifications. qPCR of liver and VAT samples was carried out on a 96.96 Dynamic Array IFC chip (Standard Biotools) on a BioMark real-time PCR platform according to the manufacturer&#8217;s specifications. A panel of 96 primer pairs representing 91 different genes was applied for quantification of gene expression in liver and VAT, including a selection of potential reference genes (Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>). The final primer concentration was 5&#8201;&#181;M.</p><p id="Par34">qPCR efficiency and dynamic range for each primer pair was determined on the basis of serial dilutions generated from individual pools made from cDNA from liver, VAT and blood samples, respectively. qPCR data were inspected in Fluidigm Real-Time PCR Analysis software 4.7.1 (Standard Biotools) and processed using GenEx7 Pro software (MultiD Analyses AB). Reverse-transcription qPCR of one VAT sample from the SD group was found to have been unsuccessful, leaving three VAT samples for gene expression analysis in this group. Qualification cycle (<italic toggle="yes">C</italic><sub>q</sub>) values were corrected using PCR efficiencies (qPCR efficiencies between 90% and 110% were accepted) and normalized to the most stable reference genes identified using NormFinder<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and geNorm<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Actin beta (<italic toggle="yes">ACTB</italic>), glyceraldehyde-3-phosphate dehydrogenase (<italic toggle="yes">GAPDH</italic>) and tyrosine 3-monooxygenase (<italic toggle="yes">YWHAZ</italic>) and <italic toggle="yes">ACTB</italic>, <italic toggle="yes">GAPDH</italic>, ribosomal protein L13a (<italic toggle="yes">RPL13A</italic>), peptidylprolyl isomerase A (<italic toggle="yes">PPIA</italic>) and <italic toggle="yes">YWHAZ</italic> were used for data normalization in liver and VAT samples, respectively. cDNA replicates were averaged, and relative quantities were calculated by scaling data relative to the sample with the lowest expression for each assay.</p></sec><sec id="Sec17"><title>LPS quantitation by Limulus amebocyte lysate assay</title><p id="Par35">LPS concentration, quantified by Limulus amebocyte lysate in serum samples on day 99, was determined in duplicates using Pierce Chromogenic Endotoxin Quant Kit (Thermo Fisher Scientific), following the manufacturer&#8217;s specifications. Serial dilutions of LPS in pretreated serum (diluted 1:100 in endotoxin-free water and heated at 70&#8201;&#176;C for 15&#8201;min) from two HFFC-fed pigs and two SD-fed pigs were included in the assay to test for the presence of interfering substances in the serum.</p></sec><sec id="Sec18"><title>Histology</title><p id="Par36">Liver tissue and VAT samples from four HFFC-fed and four SD-fed pigs were histologically examined by hematoxylin and eosin staining and Sudan III staining. Tissue samples were fixed in 10% neutral buffered formalin, embedded in paraffin wax, sectioned at 3&#8211;5&#8201;&#956;m and stained with hematoxylin and eosin. Sudan III staining for lipids was performed on selected samples of the formalin-fixed tissues. The selected samples were transferred to 85% sucrose solution and frozen at &#8722;18&#8201;&#176;C, then cryo-sectioned at 3&#8211;5&#8201;&#181;m and stained by the Sudan III method.</p><p id="Par37">The histopathological examination was performed blinded and systematically. A Leica DMRB microscope was used for reading, and images were obtained using a Leica MC120 HD camera and Leica Application Suite software, version 4.7.0 (Leica Microsystems).</p></sec><sec id="Sec19"><title>Data and statistical analysis</title><p id="Par38">All data analysis was performed in a blinded manner. Data normality was assessed using the Shapiro&#8211;Wilk test. Mixed analysis of variance was used to test the effect of diet and time on leukocyte gene expression data. When Mauchly&#8217;s test indicated violation of sphericity, Greenhouse&#8211;Geisser corrections were applied. Post-hoc analyses used two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests with Benjamini&#8211;Hochberg correction (<italic toggle="yes">&#945;</italic>&#8201;=&#8201;0.05). Differences in BW, ABC, CRP, triglyceride, total cholesterol, LDL and HDL concentrations as well as neutrophil and monocyte cell counts were analyzed using two-sided Welch&#8217;s <italic toggle="yes">t</italic>-tests with Benjamini&#8211;Hochberg corrections. Differences in LPS concentrations between diet groups on day 99 were analyzed using two-sided Welch&#8217;s <italic toggle="yes">t</italic>-test. Transcriptional data from blood samples were log<sub>2</sub>-transformed before statistical analysis. Two-sided Welch&#8217;s <italic toggle="yes">t</italic>-test was used for post-hoc analyses, and the resulting <italic toggle="yes">P</italic> values were adjusted for all genes using the Benjamini&#8211;Hochberg correction (<italic toggle="yes">&#945;</italic>&#8201;=&#8201;0.05).</p><p id="Par39">Correlation between CRP concentrations and BW, ABC, triglycerides, total cholesterol, LDL, HDL and LPS concentrations was determined using Spearman&#8217;s correlation coefficient, <italic toggle="yes">r</italic><sub>S</sub>, with significance level <italic toggle="yes">&#945;</italic>&#8201;=&#8201;0.05. As sample sizes for transcriptional analysis of liver tissue and VAT were small (<italic toggle="yes">n</italic>&#8201;=&#8201;4 for liver and VAT in the HFFC group; <italic toggle="yes">n</italic>&#8201;=&#8201;4 for liver and <italic toggle="yes">n</italic>&#8201;=&#8201;3 for VAT in the SD group), only descriptive statistics were applied. A criterion of &#8805;2-fold up- or downregulation, combined with nonoverlapping standard errors of the mean (s.e.m.), was used to identify genes that were differentially expressed between the HFFC and SD groups.</p></sec><sec id="Sec20"><title>Reporting summary</title><p id="Par40">Further information on research design is available in the <xref rid="MOESM2" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec21" sec-type="materials|methods"><title>Online content</title><p id="Par41">Any methods, additional references, Nature Portfolio reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41684-025-01588-3.</p></sec><sec id="Sec22" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="41684_2025_1588_MOESM1_ESM.pdf" position="float" orientation="portrait"><label>Supplementary Information</label><caption><p>Supplementary Tables 1&#8211;6.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xlink:href="41684_2025_1588_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Peter M. H. Heegaard, Kerstin Skovgaard.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41684-025-01588-3.</p></sec><ack><title>Acknowledgements</title><p>We thank technicians and students for their technical work in the laboratory. We thank all staff involved with the animal experiment at Lindholm. The work presented in this Article is part of the FluZooMark project supported by Novo Nordisk Foundation (grant no. NNF19OC0056326) and Independent Research Fund Denmark, Technology and Production Sciences (grant no. 3105-00073B).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>S.M.R.S.: experimental design, lead on experimental study, data curation, formal analysis, visualization, investigation, methodology, writing&#8212;original draft, writing&#8212;review and editing. B.L.H.: data curation, formal analysis, investigation, writing&#8212;review and editing. L.B.: formal analysis, investigation, writing&#8212;review and editing. E.E.J.: data curation, formal analysis, investigation, writing&#8212;review and editing. T.K.J.: data curation, formal analysis, investigation, writing&#8212;review and editing. S.G.: funding acquisition, writing&#8212;review and editing. P.M.H.H.: experimental design, investigation, methodology, supervision, writing&#8212;review and editing. K.S.: experimental design, funding acquisition, investigation, methodology, project administration, resources, supervision, writing&#8212;review and editing.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par42"><italic toggle="yes">Lab Animal</italic> thanks Jesus Osada and Noel Caplice for their contribution to the peer review of this work.</p></sec></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by Technical University of Denmark.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data that support the findings of this study are available from the corresponding author upon request.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par43">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><article-title>Inflammation, metaflammation and immunometabolic disorders</article-title><source>Nature</source><year>2017</year><volume>542</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">28179656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature21363</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. <italic toggle="yes">Nature</italic><bold>542</bold>, 177&#8211;185 (2017).<pub-id pub-id-type="pmid">28179656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature21363</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Non-communicable diseases. <italic toggle="yes">WHO</italic><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases">https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases</ext-link> (2022).</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alberti</surname><given-names>KGMM</given-names></name><etal/></person-group><article-title>Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity</article-title><source>Circulation</source><year>2009</year><volume>120</volume><fpage>1640</fpage><lpage>1645</lpage><pub-id pub-id-type="pmid">19805654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.109.192644</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Alberti, K. G. M. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. <italic toggle="yes">Circulation</italic><bold>120</bold>, 1640&#8211;1645 (2009).<pub-id pub-id-type="pmid">19805654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.109.192644</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hulme</surname><given-names>KD</given-names></name><name name-style="western"><surname>Noye</surname><given-names>EC</given-names></name><name name-style="western"><surname>Short</surname><given-names>KR</given-names></name><name name-style="western"><surname>Labzin</surname><given-names>LI</given-names></name></person-group><article-title>Dysregulated inflammation during obesity: driving disease severity in influenza virus and SARS-CoV-2 infections</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.770066</pub-id><pub-id pub-id-type="pmcid">PMC8581451</pub-id><pub-id pub-id-type="pmid">34777390</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Hulme, K. D., Noye, E. C., Short, K. R. &amp; Labzin, L. I. Dysregulated inflammation during obesity: driving disease severity in influenza virus and SARS-CoV-2 infections. <italic toggle="yes">Front. Immunol.</italic><bold>12</bold>, 1&#8211;25 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.770066</pub-id><pub-id pub-id-type="pmcid">PMC8581451</pub-id><pub-id pub-id-type="pmid">34777390</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><article-title>Inflammation and metabolic disorders</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>860</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">17167474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature05485</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Hotamisligil, G. S. Inflammation and metabolic disorders. <italic toggle="yes">Nature</italic><bold>444</bold>, 860&#8211;867 (2006).<pub-id pub-id-type="pmid">17167474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature05485</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouter</surname><given-names>LM</given-names></name><name name-style="western"><surname>McQuillan</surname><given-names>GM</given-names></name><name name-style="western"><surname>Wener</surname><given-names>MH</given-names></name><name name-style="western"><surname>Harris</surname><given-names>TB</given-names></name></person-group><article-title>Elevated C-reactive protein levels in overweight and obese adults</article-title><source>J. Am. Med. Assoc.</source><year>1999</year><volume>282</volume><fpage>2131</fpage><lpage>2135</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.282.22.2131</pub-id><pub-id pub-id-type="pmid">10591334</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H. &amp; Harris, T. B. Elevated C-reactive protein levels in overweight and obese adults. <italic toggle="yes">J. Am. Med. Assoc.</italic><bold>282</bold>, 2131&#8211;2135 (1999).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.282.22.2131</pub-id><pub-id pub-id-type="pmid">10591334</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouter</surname><given-names>LM</given-names></name><name name-style="western"><surname>McQuillan</surname><given-names>GM</given-names></name><name name-style="western"><surname>Wener</surname><given-names>MH</given-names></name><name name-style="western"><surname>Harris</surname><given-names>TB</given-names></name></person-group><article-title>Low-grade systemic inflammation in overweight children</article-title><source>Pediatrics</source><year>2001</year><volume>107</volume><fpage>E13</fpage><pub-id pub-id-type="pmid">11134477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.107.1.e13</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H. &amp; Harris, T. B. Low-grade systemic inflammation in overweight children. <italic toggle="yes">Pediatrics</italic><bold>107</bold>, E13 (2001).<pub-id pub-id-type="pmid">11134477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.107.1.e13</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unger</surname><given-names>RH</given-names></name><name name-style="western"><surname>Orci</surname><given-names>L</given-names></name></person-group><article-title>Lipotoxic diseases of nonadipose tissues in obesity</article-title><source>Int. J. Obes.</source><year>2000</year><volume>24</volume><fpage>S28</fpage><lpage>S32</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0801498</pub-id><pub-id pub-id-type="pmid">11126236</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Unger, R. H. &amp; Orci, L. Lipotoxic diseases of nonadipose tissues in obesity. <italic toggle="yes">Int. J. Obes.</italic><bold>24</bold>, S28&#8211;S32 (2000).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0801498</pub-id><pub-id pub-id-type="pmid">11126236</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engin</surname><given-names>AB</given-names></name></person-group><article-title>What is lipotoxicity?</article-title><source>Adv. Exp. Med. Biol.</source><year>2017</year><volume>960</volume><fpage>197</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">28585200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-319-48382-5_8</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Engin, A. B. What is lipotoxicity? <italic toggle="yes">Adv. Exp. Med. Biol.</italic><bold>960</bold>, 197&#8211;220 (2017).<pub-id pub-id-type="pmid">28585200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-319-48382-5_8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hase</surname><given-names>K</given-names></name></person-group><article-title>Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><fpage>673708</fpage><pub-id pub-id-type="pmid">33968085</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.673708</pub-id><pub-id pub-id-type="pmcid">PMC8100306</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Kinashi, Y. &amp; Hase, K. Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity. <italic toggle="yes">Front. Immunol.</italic><bold>12</bold>, 673708 (2021).<pub-id pub-id-type="pmid">33968085</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.673708</pub-id><pub-id pub-id-type="pmcid">PMC8100306</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litten-Brown</surname><given-names>JC</given-names></name><name name-style="western"><surname>Corson</surname><given-names>AM</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>L</given-names></name></person-group><article-title>Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview</article-title><source>Animal</source><year>2010</year><volume>4</volume><fpage>899</fpage><lpage>920</lpage><pub-id pub-id-type="pmid">22444262</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1751731110000200</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Litten-Brown, J. C., Corson, A. M. &amp; Clarke, L. Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. <italic toggle="yes">Animal</italic><bold>4</bold>, 899&#8211;920 (2010).<pub-id pub-id-type="pmid">22444262</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1751731110000200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cluzel</surname><given-names>GL</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>PM</given-names></name><name name-style="western"><surname>Herisson</surname><given-names>FM</given-names></name><name name-style="western"><surname>Caplice</surname><given-names>NM</given-names></name></person-group><article-title>High-fidelity porcine models of metabolic syndrome: a contemporary synthesis</article-title><source>Am. J. Physiol. Endocrinol. Metab.</source><year>2022</year><volume>322</volume><fpage>E366</fpage><lpage>E381</lpage><pub-id pub-id-type="pmid">35224983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpendo.00413.2021</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Cluzel, G. L., Ryan, P. M., Herisson, F. M. &amp; Caplice, N. M. High-fidelity porcine models of metabolic syndrome: a contemporary synthesis. <italic toggle="yes">Am. J. Physiol. Endocrinol. Metab.</italic><bold>322</bold>, E366&#8211;E381 (2022).<pub-id pub-id-type="pmid">35224983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpendo.00413.2021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starb&#230;k</surname><given-names>SMR</given-names></name><etal/></person-group><article-title>Animal models for influenza A virus infection incorporating the involvement of innate host defenses: enhanced translational value of the porcine model</article-title><source>ILAR J.</source><year>2018</year><volume>59</volume><fpage>323</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">30476076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ilar/ily009</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Starb&#230;k, S. M. R. et al. Animal models for influenza A virus infection incorporating the involvement of innate host defenses: enhanced translational value of the porcine model. <italic toggle="yes">ILAR J.</italic><bold>59</bold>, 323&#8211;337 (2018).<pub-id pub-id-type="pmid">30476076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ilar/ily009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sturek</surname><given-names>M</given-names></name><name name-style="western"><surname>Alloosh</surname><given-names>M</given-names></name><name name-style="western"><surname>Sellke</surname><given-names>FW</given-names></name></person-group><article-title>Swine disease models for optimal vascular engineering</article-title><source>Annu. Rev. Biomed. Eng.</source><year>2020</year><volume>22</volume><fpage>25</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">32119784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-bioeng-082919-053009</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Sturek, M., Alloosh, M. &amp; Sellke, F. W. Swine disease models for optimal vascular engineering. <italic toggle="yes">Annu. Rev. Biomed. Eng.</italic><bold>22</bold>, 25&#8211;49 (2020).<pub-id pub-id-type="pmid">32119784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-bioeng-082919-053009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zettler</surname><given-names>S</given-names></name><etal/></person-group><article-title>A decade of experience with genetically tailored pig models for diabetes and metabolic research</article-title><source>Anim. Reprod.</source><year>2020</year><volume>17</volume><fpage>e20200064</fpage><pub-id pub-id-type="pmid">33029223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/1984-3143-AR2020-0064</pub-id><pub-id pub-id-type="pmcid">PMC7534555</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Zettler, S. et al. A decade of experience with genetically tailored pig models for diabetes and metabolic research. <italic toggle="yes">Anim. Reprod.</italic><bold>17</bold>, e20200064 (2020).<pub-id pub-id-type="pmid">33029223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/1984-3143-AR2020-0064</pub-id><pub-id pub-id-type="pmcid">PMC7534555</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>N</given-names></name><name name-style="western"><surname>Du</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name></person-group><article-title>Advances in pig models of human diseases</article-title><source>Anim. Model Exp. Med.</source><year>2022</year><volume>5</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ame2.12223</pub-id><pub-id pub-id-type="pmcid">PMC9043727</pub-id><pub-id pub-id-type="pmid">35343091</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Hou, N., Du, X. &amp; Wu, S. Advances in pig models of human diseases. <italic toggle="yes">Anim. Model Exp. Med.</italic><bold>5</bold>, 141&#8211;152 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ame2.12223</pub-id><pub-id pub-id-type="pmcid">PMC9043727</pub-id><pub-id pub-id-type="pmid">35343091</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bollen</surname><given-names>PJA</given-names></name><name name-style="western"><surname>Madsen</surname><given-names>LW</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>O</given-names></name><name name-style="western"><surname>Ritskes-Hoitinga</surname><given-names>J</given-names></name></person-group><article-title>Growth differences of male and female G&#246;ttingen minipigs during ad libitum feeding: a pilot study</article-title><source>Lab Anim.</source><year>2005</year><volume>39</volume><fpage>80</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15703128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1258/0023677052886565</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Bollen, P. J. A., Madsen, L. W., Meyer, O. &amp; Ritskes-Hoitinga, J. Growth differences of male and female G&#246;ttingen minipigs during ad libitum feeding: a pilot study. <italic toggle="yes">Lab Anim.</italic><bold>39</bold>, 80&#8211;93 (2005).<pub-id pub-id-type="pmid">15703128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1258/0023677052886565</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>R&#248;dgaard</surname><given-names>T</given-names></name><etal/></person-group><article-title>Extensive changes in innate immune gene expression in obese G&#246;ttingen minipigs do not lead to changes in concentrations of circulating cytokines and acute phase proteins</article-title><source>Anim. Genet.</source><year>2014</year><volume>45</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">24106888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/age.12090</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">R&#248;dgaard, T. et al. Extensive changes in innate immune gene expression in obese G&#246;ttingen minipigs do not lead to changes in concentrations of circulating cytokines and acute phase proteins. <italic toggle="yes">Anim. Genet.</italic><bold>45</bold>, 67&#8211;73 (2014).<pub-id pub-id-type="pmid">24106888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/age.12090</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boonen</surname><given-names>HCM</given-names></name><etal/></person-group><article-title>Functional network analysis of obese and lean G&#246;ttingen minipigs elucidates changes in oxidative and inflammatory networks in obese pigs</article-title><source>Pflugers Arch.</source><year>2014</year><volume>466</volume><fpage>2167</fpage><lpage>2176</lpage><pub-id pub-id-type="pmid">24590510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00424-014-1486-2</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Boonen, H. C. M. et al. Functional network analysis of obese and lean G&#246;ttingen minipigs elucidates changes in oxidative and inflammatory networks in obese pigs. <italic toggle="yes">Pflugers Arch.</italic><bold>466</bold>, 2167&#8211;2176 (2014).<pub-id pub-id-type="pmid">24590510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00424-014-1486-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christoffersen</surname><given-names>B&#216;</given-names></name><etal/></person-group><article-title>Age- and sex-associated effects on acute-phase proteins in G&#246;ttingen minipigs</article-title><source>Comp. Med.</source><year>2015</year><volume>65</volume><fpage>333</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">26310463</pub-id><pub-id pub-id-type="pmcid">PMC4549679</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Christoffersen, B. &#216;. et al. Age- and sex-associated effects on acute-phase proteins in G&#246;ttingen minipigs. <italic toggle="yes">Comp. Med.</italic><bold>65</bold>, 333&#8211;341 (2015).<pub-id pub-id-type="pmid">26310463</pub-id><pub-id pub-id-type="pmcid">PMC4549679</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>A nutritional nonalcoholic steatohepatitis minipig model</article-title><source>J. Nutr. Biochem.</source><year>2016</year><volume>28</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">26878782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jnutbio.2015.09.029</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Li, S. J. et al. A nutritional nonalcoholic steatohepatitis minipig model. <italic toggle="yes">J. Nutr. Biochem.</italic><bold>28</bold>, 51&#8211;60 (2016).<pub-id pub-id-type="pmid">26878782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jnutbio.2015.09.029</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>L</given-names></name><etal/></person-group><article-title>Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine</article-title><source>Hepatology</source><year>2009</year><volume>50</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">19434740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.22904</pub-id><pub-id pub-id-type="pmcid">PMC3254146</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Lee, L. et al. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. <italic toggle="yes">Hepatology</italic><bold>50</bold>, 56&#8211;67 (2009).<pub-id pub-id-type="pmid">19434740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.22904</pub-id><pub-id pub-id-type="pmcid">PMC3254146</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kullo</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Hensrud</surname><given-names>DD</given-names></name><name name-style="western"><surname>Allison</surname><given-names>TG</given-names></name></person-group><article-title>Comparison of numbers of circulating blood monocytes in men grouped by body mass index (&lt;25, 25 to &lt;30, &#8805;30)</article-title><source>Am. J. Cardiol.</source><year>2002</year><volume>89</volume><fpage>1441</fpage><lpage>1443</lpage><pub-id pub-id-type="pmid">12062747</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9149(02)02366-4</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kullo, I. J., Hensrud, D. D. &amp; Allison, T. G. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (&lt;25, 25 to &lt;30, &#8805;30). <italic toggle="yes">Am. J. Cardiol.</italic><bold>89</bold>, 1441&#8211;1443 (2002).<pub-id pub-id-type="pmid">12062747</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9149(02)02366-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>C</given-names></name><name name-style="western"><surname>Guimar&#227;es</surname><given-names>JT</given-names></name><name name-style="western"><surname>Barros</surname><given-names>H</given-names></name></person-group><article-title>Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome</article-title><source>Int. J. Obes.</source><year>2005</year><volume>29</volume><fpage>1452</fpage><lpage>1456</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0803035</pub-id><pub-id pub-id-type="pmid">16077717</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Santos, A. C., Lopes, C., Guimar&#227;es, J. T. &amp; Barros, H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. <italic toggle="yes">Int. J. Obes.</italic><bold>29</bold>, 1452&#8211;1456 (2005).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0803035</pub-id><pub-id pub-id-type="pmid">16077717</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aronson</surname><given-names>D</given-names></name><etal/></person-group><article-title>Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome</article-title><source>Int. J. Obes.</source><year>2004</year><volume>28</volume><fpage>674</fpage><lpage>679</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0802609</pub-id><pub-id pub-id-type="pmid">14993913</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Aronson, D. et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. <italic toggle="yes">Int. J. Obes.</italic><bold>28</bold>, 674&#8211;679 (2004).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0802609</pub-id><pub-id pub-id-type="pmid">14993913</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattos</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Chronic low-grade inflammation in childhood obesity is associated with decreased IL-10 expression by monocyte subsets</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0168610</fpage><pub-id pub-id-type="pmid">27977792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0168610</pub-id><pub-id pub-id-type="pmcid">PMC5158089</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Mattos, R. T. et al. Chronic low-grade inflammation in childhood obesity is associated with decreased IL-10 expression by monocyte subsets. <italic toggle="yes">PLoS ONE</italic><bold>11</bold>, e0168610 (2016).<pub-id pub-id-type="pmid">27977792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0168610</pub-id><pub-id pub-id-type="pmcid">PMC5158089</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>W&#228;rnberg</surname><given-names>J</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>LA</given-names></name><name name-style="western"><surname>Mesana</surname><given-names>MI</given-names></name><name name-style="western"><surname>Marcos</surname><given-names>A</given-names></name></person-group><article-title>Inflammatory mediators in overweight and obese Spanish adolescents. The AVENA Study</article-title><source>Int. J. Obes. Relat. Metab. Disord.</source><year>2004</year><volume>28</volume><fpage>S59</fpage><lpage>S63</lpage><pub-id pub-id-type="pmid">15543221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0802809</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">W&#228;rnberg, J., Moreno, L. A., Mesana, M. I. &amp; Marcos, A. Inflammatory mediators in overweight and obese Spanish adolescents. The AVENA Study. <italic toggle="yes">Int. J. Obes. Relat. Metab. Disord.</italic><bold>28</bold>, S59&#8211;S63 (2004).<pub-id pub-id-type="pmid">15543221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.ijo.0802809</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vasiljevic</surname><given-names>ANKND</given-names></name><name name-style="western"><surname>Simic</surname><given-names>TP</given-names></name><name name-style="western"><surname>Djukic</surname><given-names>TI</given-names></name><name name-style="western"><surname>Maksimovic</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Matic</surname><given-names>MG</given-names></name></person-group><article-title>Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro</article-title><source>Lab. Med.</source><year>2014</year><volume>45</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">24719979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1309/lmi6i2rn7ampeuul</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Vasiljevic, A. N. K. N. D., Simic, T. P., Djukic, T. I., Maksimovic, M. Z. &amp; Matic, M. G. Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro. <italic toggle="yes">Lab. Med.</italic><bold>45</bold>, 12&#8211;16 (2014).<pub-id pub-id-type="pmid">24719979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1309/lmi6i2rn7ampeuul</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choromanska</surname><given-names>B</given-names></name><etal/></person-group><article-title>The implication of adipocyte ATP-binding cassette A1 and G1 transporters in metabolic complications of obesity</article-title><source>J. Physiol. Pharmacol.</source><year>2019</year><volume>70</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.26402/jpp.2019.1.14</pub-id><pub-id pub-id-type="pmid">31172973</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Choromanska, B. et al. The implication of adipocyte ATP-binding cassette A1 and G1 transporters in metabolic complications of obesity. <italic toggle="yes">J. Physiol. Pharmacol.</italic><bold>70</bold>, 143&#8211;152 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.26402/jpp.2019.1.14</pub-id><pub-id pub-id-type="pmid">31172973</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study</article-title><source>Lancet</source><year>1999</year><volume>353</volume><fpage>1649</fpage><lpage>1652</lpage><pub-id pub-id-type="pmid">10335783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(99)01046-6</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Schmidt, M. I. et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. <italic toggle="yes">Lancet</italic><bold>353</bold>, 1649&#8211;1652 (1999).<pub-id pub-id-type="pmid">10335783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(99)01046-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schipper</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><fpage>2800</fpage><lpage>2810</lpage><pub-id pub-id-type="pmid">22806355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-012-2641-y</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Schipper, H. S. et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. <italic toggle="yes">Diabetologia</italic><bold>55</bold>, 2800&#8211;2810 (2012).<pub-id pub-id-type="pmid">22806355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-012-2641-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertoni</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Inflammation and the incidence of type 2 diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>804</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">20097779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc09-1679</pub-id><pub-id pub-id-type="pmcid">PMC2845031</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Bertoni, A. G. et al. Inflammation and the incidence of type 2 diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA). <italic toggle="yes">Diabetes Care</italic><bold>33</bold>, 804&#8211;810 (2010).<pub-id pub-id-type="pmid">20097779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc09-1679</pub-id><pub-id pub-id-type="pmcid">PMC2845031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanmani</surname><given-names>S</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>M</given-names></name><name name-style="western"><surname>Shin</surname><given-names>M</given-names></name><name name-style="western"><surname>Kim</surname><given-names>MK</given-names></name></person-group><article-title>Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>4573</fpage><pub-id pub-id-type="pmid">30872696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-40987-8</pub-id><pub-id pub-id-type="pmcid">PMC6418102</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Kanmani, S., Kwon, M., Shin, M. &amp; Kim, M. K. Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 4573 (2019).<pub-id pub-id-type="pmid">30872696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-40987-8</pub-id><pub-id pub-id-type="pmcid">PMC6418102</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ludvigsen</surname><given-names>TP</given-names></name><etal/></person-group><article-title>G&#246;ttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals</article-title><source>J. Transl. Med.</source><year>2015</year><volume>13</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">26394837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-015-0670-2</pub-id><pub-id pub-id-type="pmcid">PMC4580291</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Ludvigsen, T. P. et al. G&#246;ttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals. <italic toggle="yes">J. Transl. Med.</italic><bold>13</bold>, 1&#8211;12 (2015).<pub-id pub-id-type="pmid">26394837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-015-0670-2</pub-id><pub-id pub-id-type="pmcid">PMC4580291</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#252;tzh&#248;ft</surname><given-names>DO</given-names></name><etal/></person-group><article-title>High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young G&#246;ttingen minipigs</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0298602</pub-id><pub-id pub-id-type="pmcid">PMC10906878</pub-id><pub-id pub-id-type="pmid">38427692</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">L&#252;tzh&#248;ft, D. O. et al. High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young G&#246;ttingen minipigs. <italic toggle="yes">PLoS ONE</italic><bold>19</bold>, 1&#8211;27 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0298602</pub-id><pub-id pub-id-type="pmcid">PMC10906878</pub-id><pub-id pub-id-type="pmid">38427692</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansen</surname><given-names>T</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>HS</given-names></name><name name-style="western"><surname>Richelsen</surname><given-names>B</given-names></name><name name-style="western"><surname>Malml&#246;f</surname><given-names>K</given-names></name></person-group><article-title>The obese G&#246;ttingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile</article-title><source>Comp. Med.</source><year>2001</year><volume>51</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11922179</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Johansen, T., Hansen, H. S., Richelsen, B. &amp; Malml&#246;f, K. The obese G&#246;ttingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. <italic toggle="yes">Comp. Med.</italic><bold>51</bold>, 150&#8211;155 (2001).<pub-id pub-id-type="pmid">11922179</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andreasen</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Dietary normalization from a fat, fructose and cholesterol-rich diet to chow limits the amount of myocardial collagen in a G&#246;ttingen minipig model of obesity</article-title><source>Nutr. Metab.</source><year>2018</year><volume>15</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12986-018-0303-x</pub-id><pub-id pub-id-type="pmcid">PMC6157063</pub-id><pub-id pub-id-type="pmid">30263039</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Andreasen, L. J. et al. Dietary normalization from a fat, fructose and cholesterol-rich diet to chow limits the amount of myocardial collagen in a G&#246;ttingen minipig model of obesity. <italic toggle="yes">Nutr. Metab.</italic><bold>15</bold>, 1&#8211;12 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12986-018-0303-x</pub-id><pub-id pub-id-type="pmcid">PMC6157063</pub-id><pub-id pub-id-type="pmid">30263039</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schumacher-Petersen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Experimental non-alcoholic steatohepatitis in G&#246;ttingen minipigs: consequences of high fat-fructose-cholesterol diet and diabetes</article-title><source>J. Transl. Med.</source><year>2019</year><volume>17</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">30943987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-019-1854-y</pub-id><pub-id pub-id-type="pmcid">PMC6448276</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Schumacher-Petersen, C. et al. Experimental non-alcoholic steatohepatitis in G&#246;ttingen minipigs: consequences of high fat-fructose-cholesterol diet and diabetes. <italic toggle="yes">J. Transl. Med.</italic><bold>17</bold>, 1&#8211;18 (2019).<pub-id pub-id-type="pmid">30943987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-019-1854-y</pub-id><pub-id pub-id-type="pmcid">PMC6448276</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renner</surname><given-names>S</given-names></name><etal/></person-group><article-title>Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese G&#246;ttingen minipigs</article-title><source>Mol. Metab.</source><year>2018</year><volume>16</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">30017782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molmet.2018.06.015</pub-id><pub-id pub-id-type="pmcid">PMC6157610</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Renner, S. et al. Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese G&#246;ttingen minipigs. <italic toggle="yes">Mol. Metab.</italic><bold>16</bold>, 180&#8211;190 (2018).<pub-id pub-id-type="pmid">30017782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molmet.2018.06.015</pub-id><pub-id pub-id-type="pmcid">PMC6157610</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirera</surname><given-names>S</given-names></name><etal/></person-group><article-title>The expression signatures in liver and adipose tissue from obese G&#246;ttingen minipigs reveal a predisposition for healthy fat accumulation</article-title><source>Nutr. Diabetes</source><year>2020</year><volume>10</volume><fpage>9</fpage><pub-id pub-id-type="pmid">32205840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41387-020-0112-y</pub-id><pub-id pub-id-type="pmcid">PMC7090036</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Cirera, S. et al. The expression signatures in liver and adipose tissue from obese G&#246;ttingen minipigs reveal a predisposition for healthy fat accumulation. <italic toggle="yes">Nutr. Diabetes</italic><bold>10</bold>, 9 (2020).<pub-id pub-id-type="pmid">32205840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41387-020-0112-y</pub-id><pub-id pub-id-type="pmcid">PMC7090036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herisson</surname><given-names>FM</given-names></name><etal/></person-group><article-title>Targeting the gut&#8211;heart axis improves cardiac remodeling in a clinical scale model of cardiometabolic syndrome</article-title><source>JACC Basic Transl. Sci.</source><year>2024</year><volume>10</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">39906593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacbts.2024.09.004</pub-id><pub-id pub-id-type="pmcid">PMC11788474</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Herisson, F. M. et al. Targeting the gut&#8211;heart axis improves cardiac remodeling in a clinical scale model of cardiometabolic syndrome. <italic toggle="yes">JACC Basic Transl. Sci.</italic><bold>10</bold>, 1&#8211;15 (2024).<pub-id pub-id-type="pmid">39906593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacbts.2024.09.004</pub-id><pub-id pub-id-type="pmcid">PMC11788474</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cani</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Metabolic endotoxemia initiates obesity and insulin resistance</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><fpage>1761</fpage><lpage>1772</lpage><pub-id pub-id-type="pmid">17456850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db06-1491</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. <italic toggle="yes">Diabetes</italic><bold>56</bold>, 1761&#8211;1772 (2007).<pub-id pub-id-type="pmid">17456850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db06-1491</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>R</given-names></name><name name-style="western"><surname>Rah</surname><given-names>B</given-names></name><name name-style="western"><surname>Bastola</surname><given-names>D</given-names></name><name name-style="western"><surname>Dhawan</surname><given-names>P</given-names></name><name name-style="western"><surname>Singh</surname><given-names>AB</given-names></name></person-group><article-title>Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">28698546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-04989-8</pub-id><pub-id pub-id-type="pmcid">PMC5505957</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ahmad, R., Rah, B., Bastola, D., Dhawan, P. &amp; Singh, A. B. Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching. <italic toggle="yes">Sci. Rep.</italic><bold>7</bold>, 1&#8211;16 (2017).<pub-id pub-id-type="pmid">28698546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-04989-8</pub-id><pub-id pub-id-type="pmcid">PMC5505957</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brun</surname><given-names>P</given-names></name><name name-style="western"><surname>Castagliuolo</surname><given-names>I</given-names></name><name name-style="western"><surname>Pinzani</surname><given-names>M</given-names></name><name name-style="western"><surname>Pal&#249;</surname><given-names>G</given-names></name><name name-style="western"><surname>Martines</surname><given-names>D</given-names></name></person-group><article-title>Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2005</year><volume>289</volume><fpage>571</fpage><lpage>578</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.00537.2004</pub-id><pub-id pub-id-type="pmid">15860640</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Brun, P., Castagliuolo, I., Pinzani, M., Pal&#249;, G. &amp; Martines, D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. <italic toggle="yes">Am. J. Physiol. Gastrointest. Liver Physiol.</italic><bold>289</bold>, 571&#8211;578 (2005).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.00537.2004</pub-id><pub-id pub-id-type="pmid">15860640</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>L</given-names></name><etal/></person-group><article-title>The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases</article-title><source>J. Gastrointest. Surg.</source><year>2022</year><volume>26</volume><fpage>671</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">34734369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11605-021-05188-7</pub-id><pub-id pub-id-type="pmcid">PMC8926958</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">An, L. et al. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. <italic toggle="yes">J. Gastrointest. Surg.</italic><bold>26</bold>, 671&#8211;683 (2022).<pub-id pub-id-type="pmid">34734369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11605-021-05188-7</pub-id><pub-id pub-id-type="pmcid">PMC8926958</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tr&#248;seid</surname><given-names>M</given-names></name><etal/></person-group><article-title>Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery</article-title><source>Diabetes Care</source><year>2013</year><volume>36</volume><fpage>3627</fpage><lpage>3632</lpage><pub-id pub-id-type="pmid">23835694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc13-0451</pub-id><pub-id pub-id-type="pmcid">PMC3816876</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Tr&#248;seid, M. et al. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. <italic toggle="yes">Diabetes Care</italic><bold>36</bold>, 3627&#8211;3632 (2013).<pub-id pub-id-type="pmid">23835694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc13-0451</pub-id><pub-id pub-id-type="pmcid">PMC3816876</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hotamisligil</surname><given-names>GS</given-names></name><name name-style="western"><surname>Arner</surname><given-names>P</given-names></name><name name-style="western"><surname>Caro</surname><given-names>JF</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>RL</given-names></name><name name-style="western"><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>Increased adipose tissue expression of tumor necrosis factor-&#945; in human obesity and insulin resistance</article-title><source>J. Clin. Invest.</source><year>1995</year><volume>95</volume><fpage>2409</fpage><lpage>2415</lpage><pub-id pub-id-type="pmid">7738205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI117936</pub-id><pub-id pub-id-type="pmcid">PMC295872</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. &amp; Spiegelman, B. M. Increased adipose tissue expression of tumor necrosis factor-&#945; in human obesity and insulin resistance. <italic toggle="yes">J. Clin. Invest.</italic><bold>95</bold>, 2409&#8211;2415 (1995).<pub-id pub-id-type="pmid">7738205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI117936</pub-id><pub-id pub-id-type="pmcid">PMC295872</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Haan</surname><given-names>W</given-names></name><name name-style="western"><surname>Bhattacharjee</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruddle</surname><given-names>P</given-names></name><name name-style="western"><surname>Kang</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hayden</surname><given-names>MR</given-names></name></person-group><article-title>ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity</article-title><source>J. Lipid Res.</source><year>2014</year><volume>55</volume><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">24443560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1194/jlr.M045294</pub-id><pub-id pub-id-type="pmcid">PMC3934735</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">De Haan, W., Bhattacharjee, A., Ruddle, P., Kang, M. H. &amp; Hayden, M. R. ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity. <italic toggle="yes">J. Lipid Res.</italic><bold>55</bold>, 516&#8211;523 (2014).<pub-id pub-id-type="pmid">24443560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1194/jlr.M045294</pub-id><pub-id pub-id-type="pmcid">PMC3934735</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frisdal</surname><given-names>E</given-names></name><etal/></person-group><article-title>Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>840</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">25249572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db14-0245</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Frisdal, E. et al. Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity. <italic toggle="yes">Diabetes</italic><bold>64</bold>, 840&#8211;855 (2015).<pub-id pub-id-type="pmid">25249572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db14-0245</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dongiovanni</surname><given-names>P</given-names></name><etal/></person-group><article-title>&#946;-Klotho gene variation is associated with liver damage in children with NAFLD</article-title><source>J. Hepatol.</source><year>2020</year><volume>72</volume><fpage>411</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">31655133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2019.10.011</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Dongiovanni, P. et al. &#946;-Klotho gene variation is associated with liver damage in children with NAFLD. <italic toggle="yes">J. Hepatol.</italic><bold>72</bold>, 411&#8211;419 (2020).<pub-id pub-id-type="pmid">31655133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2019.10.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><etal/></person-group><article-title>Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis</article-title><source>Nutr. Diabetes</source><year>2024</year><volume>14</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">38609395</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41387-024-00277-3</pub-id><pub-id pub-id-type="pmcid">PMC11014968</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Guo, W. et al. Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis. <italic toggle="yes">Nutr. Diabetes</italic><bold>14</bold>, 1&#8211;10 (2024).<pub-id pub-id-type="pmid">38609395</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41387-024-00277-3</pub-id><pub-id pub-id-type="pmcid">PMC11014968</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mladeni&#263;</surname><given-names>K</given-names></name><name name-style="western"><surname>Lenarti&#263;</surname><given-names>M</given-names></name><name name-style="western"><surname>Marinovi&#263;</surname><given-names>S</given-names></name><name name-style="western"><surname>Poli&#263;</surname><given-names>B</given-names></name><name name-style="western"><surname>Wensveen</surname><given-names>FM</given-names></name></person-group><article-title>The &#8216;Domino effect&#8217; in MASLD: the inflammatory cascade of steatohepatitis</article-title><source>Eur. J. Immunol.</source><year>2024</year><volume>54</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.202149641</pub-id><pub-id pub-id-type="pmid">38314819</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Mladeni&#263;, K., Lenarti&#263;, M., Marinovi&#263;, S., Poli&#263;, B. &amp; Wensveen, F. M. The &#8216;Domino effect&#8217; in MASLD: the inflammatory cascade of steatohepatitis. <italic toggle="yes">Eur. J. Immunol.</italic><bold>54</bold>, 1&#8211;11 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.202149641</pub-id><pub-id pub-id-type="pmid">38314819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heegaard</surname><given-names>PMH</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>HG</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>AL</given-names></name><name name-style="western"><surname>Boas</surname><given-names>U</given-names></name></person-group><article-title>A robust quantitative solid phase immunoassay for the acute phase protein C-reactive protein (CRP) based on cytidine 5&#8242;-diphosphocholine coupled dendrimers</article-title><source>J. Immunol. Methods</source><year>2009</year><volume>343</volume><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">19236874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jim.2009.02.002</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Heegaard, P. M. H., Pedersen, H. G., Jensen, A. L. &amp; Boas, U. A robust quantitative solid phase immunoassay for the acute phase protein C-reactive protein (CRP) based on cytidine 5&#8242;-diphosphocholine coupled dendrimers. <italic toggle="yes">J. Immunol. Methods</italic><bold>343</bold>, 112&#8211;118 (2009).<pub-id pub-id-type="pmid">19236874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jim.2009.02.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>CL</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>JL</given-names></name><name name-style="western"><surname>&#216;rntoft</surname><given-names>TF</given-names></name></person-group><article-title>Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets</article-title><source>Cancer Res.</source><year>2004</year><volume>64</volume><fpage>5245</fpage><lpage>5250</lpage><pub-id pub-id-type="pmid">15289330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-04-0496</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Andersen, C. L., Jensen, J. L. &amp; &#216;rntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. <italic toggle="yes">Cancer Res.</italic><bold>64</bold>, 5245&#8211;5250 (2004).<pub-id pub-id-type="pmid">15289330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-04-0496</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandesompele</surname><given-names>J</given-names></name><etal/></person-group><article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title><source>Genome Biol.</source><year>2002</year><volume>3</volume><fpage>RESEARCH0034</fpage><pub-id pub-id-type="pmid">12184808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/gb-2002-3-7-research0034</pub-id><pub-id pub-id-type="pmcid">PMC126239</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. <italic toggle="yes">Genome Biol.</italic><bold>3</bold>, RESEARCH0034 (2002).<pub-id pub-id-type="pmid">12184808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/gb-2002-3-7-research0034</pub-id><pub-id pub-id-type="pmcid">PMC126239</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>